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ABSTRACT
Patients with life-limiting cancer and their families face unique challenges that interfere
with their ability to make decisions or adequately express their health care preferences about end
of life (EOL) treatment. As a result, patients at EOL often receive aggressive unwanted treatment
that nationally costs billions of dollars and results in surrogate distress about not honoring patient
wishes. Respecting Choices® DS-ACP is a disease-specific Advance Care Planning (ACP)
intervention that is designed to overcome barriers associated with ACP and potentially decrease
the incidence of unwanted, overly aggressive treatments at EOL. The intervention is delivered to
patient-surrogate dyads by a trained facilitator who provides an opportunity for patients to
identify values and goals that support their EOL choices and communicate these values and goals
to their surrogates before they are in a medical crisis. Although Respecting Choices® DS-ACP
has been effective with other populations, it has not been evaluated for patients with life-limiting
cancer. Thus, the purpose of this study was to evaluate the Respecting Choices® DS-ACP
intervention with patients with life-limiting cancer to determine if the intervention increases
patient-surrogate congruence about the patient’s EOL wishes and reduces decisional conflict
without causing anxiety.
Study design was a Phase I clinical trial. A volunteer sample of 15 patients with a
diagnosis of life limiting cancer and their matched surrogates participated in the study. The
Statement of Treatment Preferences for Life-Limiting Cancer Form, the Spielberger Stateanxiety Scale Form Y-1 (STAI) and the Decisional Conflict Scale (DCS) were administered preand post-intervention. The Quality of Communication about End of Life Care Form was
administered at post test. Descriptive statistics were used to describe the sample. McNemar Chisquare and Binomial tests were conducted to investigate whether the intervention increased
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congruence for five different situations on the Statement of Treatment Preferences for LifeLimiting Cancer Form. The Zar’s Multiple Comparison Test of Differences was conducted to
investigate the proportion of congruence observed across the five situations. A paired-sample t
test was conducted to evaluate post-intervention changes in anxiety (STAI) and decisional
conflict (DCS). Frequencies and percentages were conducted for the five items on the Quality of
Communication about End of Life Care Form to evaluate patients’ and surrogates’ satisfaction
with the intervention. Anecdotal comments about timing were content analyzed and
summarized.
Congruence between patients and surrogates improved significantly in all five situations
(range of p =.001 to .031), decisional conflict lessened significantly (t (14) =4.49, p < .001), and
anxiety did not change (t (14) = 1.75, p = .102) pre- and post-intervention. Participants reported
satisfaction with the intervention, including its delivery and timing.
Findings from this study provide guidance on how to assist patients with life limiting
cancer and their surrogates with EOL decision making. Study findings also support making the
Respecting Choices ACP intervention part of usual care for patients with life limiting cancer and
timing the intervention so that it is delivered before a medical crisis occurs. The lack of change
in post-intervention anxiety scores suggests that ACP does not add to patient distress when ACP
is conducted by a trained facilitator. This finding can be used to persuade health professionals to
refer their patients for ACP. Additional research is needed to determine if increased patientsurrogate congruence leads to patients’ wishes being followed and reduces surrogate decisional
conflict and distress at EOL. Future research is also needed to determine if the Respecting
Choices DS-ACP intervention is equally effective with racial and ethnic groups whose reluctance
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to engage in EOL discussion has been documented in the literature or if the intervention needs to
be culturally adapted.
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CHAPTER 1: OVERVIEW
Introduction
The study was a Phase I clinical trial to evaluate an intervention to assist patients with life
limiting cancer to formulate and express their end-of-life preferences to family members and
health care professionals. An estimated 1.5 million Americans receive a diagnosis of cancer
annually and more than 1,500 patients die every day from the disease (American Cancer Society
[ACS], 2010). Patients with life-limiting cancer and their families face unique challenges that
interfere with their ability to make decisions or adequately express their health care preferences
about end of life (EOL). Life-limiting cancer patients typically maintain good functioning for a
long period and then experience a rapid decline as the illness becomes overwhelming and leads
to death (Lorenz et al., 2008; Lynn, 2005; Morita, Tei, & Inoug, 2003; Teno, Weitzen, Fennell
& Mor, 2001). During their decline, these patients often endure intense symptoms that cause
them to lose decision-making capacity. Very often, they have not communicated their
preferences in advance to family members, leaving family members unprepared to make EOL
decisions on their behalf. As a result, life-limiting cancer patients often receive care at the EOL
that is inconsistent with their preferences (Goodman et al., 2010; McCarthy, Philips, Zhong,
Drews & Lynn, 2000; Teno, Fisher, Hamel, Coppola, & Dawson, 2002).
Advance care planning (ACP) and advance directives (ADs) provide a general
framework for decision making near the EOL by having patients identify their preferences for
life-sustaining care ahead of time before they lose decision-making ability. Instructional ADs
contain directives regarding what treatments patients want and the conditions under which they
want treatments withheld. Proxy ADs enable patients to select surrogates, people they want to
make decisions on their behalf if they are unable to do so. ACP is the process of identifying
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goals, values, and beliefs about healthcare decisions that may need to be made in the future to
assist patients and surrogates to prepare or enact instructional ADs.

Background of Problem
The Patient Self-Determination Act (PSDA) (42 U.S.C. 1395cc (a), 1990) specifies the
need for instructional or proxy ADs to improve EOL experiences by communicating patients’
wishes to family members and health professionals. The national guidelines for applying the
PSDA to cancer is for patients diagnosed with life-limiting cancer and life expectancy of 1 year
or less to have completed ACP and ADs (National Comprehensive Cancer Network [NCCN],
2010).
Despite these guidelines and two decades of legislation and studies, AD completion rates
remain low. According to various reports they are between 18%-30% (Covinsky et al., 2000;
Kish, Martin, & Price, 2000; Lo & Steinbrook, 2004; Wilkerson, Wenger, & Shugarman, 2007).
Various ACP interventions aimed at increasing the completion of effective ADs have been tried
(Coppola, Ditto, Danks, & Smucker, 2001; Ditto et.al., 2001; The SUPPORT Principal
Investigators, 1995), but most interventions have not been effective. Even when ADs have been
completed, they are often ineffective (Covinsky et al. 2000; Kish et al., 2000; Lo & Steinbrook,
2004;Wilkerson et al., 2007) leading to default medical care which often ends up being different
and more aggressive than what patients want (Goodman et al., 2010; Wennberg, Fisher,
Goodman, & Skinner, 2008).
There are a number of reasons for the lack of success with ACP and ADs. In actual
practice, health care providers typically fail to initiate meaningful advance care discussions,
perhaps because they lack the skills or time to do so (Baile, Lenzi, Parker, Buckman, & Cohen,
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2002; Curtis, Patrick, Caldwell & Collier, 2000; Fischer, Tulsky, Rose, Siminoff, & Arnold,
1998; Tung, 2009; Yedidia, 2007). As a result, patient and surrogates often lack understanding of
both the benefits and possible untoward consequences of EOL treatment options (Fried, Bradley,
Towle, & Allore, 2002). Surrogates also may not know patients’ values and decision choices
because patients and surrogates avoid discussions of EOL in order to avoid upsetting one another
(Briggs, 2003; Fried & O’Leary, 2008; Quill, 2000; Zhang & Siminoff, 2003). Additional
problems pertain to timing: If advance planning occurs too early, it may rely on hypothetical
situations. Patients cannot predict future decision choices for situations that they have not yet
experienced (Fried et al., 2002; Fried, et al., 2007). On the other hand, if AD planning is delayed
too long, ADs risk being formulated during stressful times when patients’ decision making
capacity is already compromised (Covinsky et al., 2000).

Statement of Problem
For patients with life-limiting cancer, planning for future health care decisions is more
dynamic and complex than for patients with well managed illnesses. This dynamism and
complexity poses additional ACP demands on professional facilitators, patients, and surrogates.
Respecting Choices® DS-ACP is a disease-specific ACP intervention that is designed to
overcome barriers associated with ACP and ADs. The intervention is delivered by a trained
health professional and includes both patients and surrogates. The facilitator explores the
patient’s understanding of his or her current illness, the likelihood of future complications, the
benefits and burdens of treatment options, and the patient’s values and goals (Briggs & Hammes,
2008/2010; Fried et al, 2006; Fried et al. 2002) and provides an opportunity for patients to
communicate values and beliefs that support their EOL choices to their surrogates.
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The Respecting Choices® intervention for patients and their surrogates has been
successful in various populations, including patients with chronic illnesses (Briggs, 2003; Briggs,
Kirchhoff, Hammes, Song, & Colvin, 2004; Detering, Hancock, Reade,& Silvester, 2010;
Kirchhoff, Hammes, Kehl, Briggs, & Brown, 2010), patients undergoing cardiac surgery (Song,
Kirchhoff, Douglas, Ward, & Hammes, 2005), geriatric patients (Schwartz et al., 2002), and
adolescents living with HIV ( Lyon et al., 2009). However, Respecting Choices® DS-ACP has
not been evaluated for patients with life-limiting cancer.

Purpose of Study
The purpose of this study was to evaluate whether an ACP intervention using Respecting
Choices® DS-ACP, delivered early in the cancer care continuum, increases patients and
surrogates congruence and reduces patients’ decisional conflict without causing anxiety. The
general guidelines for Respecting Choices ACP were adapted in this study to be disease- specific
for patients with life-limiting cancer.

Research Questions
The study answered the following research questions:
RQ1: Does the intervention increase congruence between patients and matched
surrogates about patients’ treatment preferences for life-limiting cancer?
RQ2: Are there significant differences in the proportion of congruence observed for
different situations post-intervention?
RQ3: Does the intervention reduce patients’ decisional conflict?
RQ4: Does the intervention increase patients’ anxiety?
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Hypotheses
Based on the proposed research questions, the following hypotheses were developed:
HA1: The intervention will increase congruence of treatment preferences for lifelimiting cancer questionnaire (pretest versus posttest) between patients and matched surrogates.
HA2: There will be significant differences in the proportion of congruence observed for
different situations post intervention.
HA3: The intervention will reduce patients’ decisional conflict.
HA4: The intervention will not increase patients’ anxiety.

Definition of Terms
The terms utilized throughout this proposal are defined as follows.
Advance care planning (ACP). A process of communication to assist individuals in
understanding, reflecting upon, and discussing their goals, values, and beliefs about future health
care decisions in the hypothetical event that individuals are no longer able to speak for
themselves (Briggs & Hammes, 2008). ACP often culminates in the creation of an advance
directive.
Advance care planning facilitator (ACP facilitator). A designated individual who has
successfully completed an advance care planning facilitator skills training program to lead
advance care planning discussions and related activities (Briggs & Hammes, 2008/2010).
Advance directives (ADs). A general term that describes two kinds of legal documents:
living wills and medical power of attorney. These documents allow a person to give instructions
about future medical care should he or she be unable to participate in medical decisions due to
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serious illness or incapacity. Each state regulates the use and application of advanced directives
differently (National Hospice and Palliative Care Organization [NHPCO], n.d.).
Decisional conflict. Uncertainty about which course of action to take when the choice
among competing actions involves risks, loss, regret, or challenges personal life values (NHPCO,
n.d.).
End of life (EOL). A variable time prior to death when an individual experiences
disability or worsening of a disease process (Briggs & Hammes, 2008/2010).
Health care provider. Any licensed professional who is responsible for delivering health
care services, including physicians, nurses, nurse practitioners, social workers, pharmacists,
respiratory therapists, and so on (Briggs & Hammes, 2008/2010).
Health care surrogate (surrogate). The person named in an advance directive or
permitted under state law to make health care decisions on behalf of the person who is no longer
able to make medical decisions (NHPCO, n.d.). “Any competent adult expressly designated by
a principle to make healthcare decisions on behalf of the principle upon the principles
incapacity” (Florida Statutes, 2009).
Life-limiting cancer. An initial or recurrent diagnosis of advanced cancer or invasive
cancer. Advanced cancer is cancer that has grown beyond the organ in which it first started or
affects a vital organ that cannot be removed. Invasive cancer is when cancer cells have
penetrated the original layer of tissue (ACS, 2010).
Life-sustaining treatment. Any intervention that prolongs life, including technical and
invasive treatment (e.g., ventilators, dialysis) or less aggressive treatments (e.g., antibiotics, IV
fluids, and tube feedings; Briggs & Hammes, 2008).
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Principle of nonabandonment. Reflects the healthcare providers’ longitudinal
commitment to care about patients and jointly seek solutions to problems with patients
throughout their illness. This open-ended commitment to face the future together becomes more
important as the future becomes less certain (Quill & Cassel, 1995).
Substituted judgment. The form of surrogate decision making regarding EOL care in
which the surrogate attempts to establish with as much accuracy as possible what decision the
patient would have made if the patient was competent to do so. This conclusion can be based on
the patient’s preference expressed in previous statements or the surrogate’s knowledge of the
patient’s beliefs, values, personality, and prior lifestyle. This standard seeks to preserve the
patient’s right of self-determination by placing the patient’s own preferences at the center of
deliberation (Ascension Health Care Ethics, n.d.: Fl. Statutes, 2009).

Assumptions
The research was based on the following assumptions:
Patients with life-limiting cancer have pre-existing knowledge and ideas (representations)
about their health problems.
Effective patient education is most likely to occur when patients’ knowledge and beliefs
(representations) are elicited before new information is provided.
Assessing patients’ representation about a health problem provides a context in which
ACP facilitators can give specific, highly relevant, individualized information that will have a
greater chance of being accepted by the patient (Donovan & Ward, 2001).
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Significance
Findings from this study provide information about how to assist patients with life
limiting cancer and their surrogates with EOL decision making. Information about an
intervention that clarifies patient wishes and increases surrogate understanding of those wishes
has the potential to not only impact patient suffering from side effects of aggressive unwanted
treatment and surrogate distress about honoring patient wishes at EOL but also reduce the
billions of dollars of unwanted treatment currently spent at EOL for patients with life-limiting
cancer (Smith & Hillner, 2011; Zhang et al., 2009). Findings from this study also answer
questions about when in the patients’ cancer trajectory is it appropriate to discuss EOL with
patients with life limiting cancer and whether these discussions increase patient anxiety.
Answering the latter question addresses provider concerns about possible negative effects of
EOL discussions, thereby removing one barrier to EOL planning.

Outline of Remainder of Dissertation
Chapter 1 has served to provide an overview of why effective interventions are needed to
improve patient-surrogate dyadic congruence and reduce patients’ decisional conflict without
causing anxiety. Chapter 2 is a review of the literature and discussion of the theoretical
framework that organizes this research project. The specific focus is literature about barriers to
completing ADs and studies that address strategies to improve EOL care so that is consistent
with patients’ preferences. These studies include a critical review of the Respecting Choices®
DS-ACP intervention and how it has been implemented and evaluated to date. Chapter 2 also
introduces the theory of the representational approach to patient education, which is the
theoretical basis to the Respecting Choices intervention. The Respecting Choices DS-ACP
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intervention, the study design and research procedures are described in Chapter 3. Chapter 4
reports the study findings. Chapter 5 discusses research questions and hypotheses supported or
refuted by the findings
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CHAPTER 2: REVIEW OF RELEVANT LITERATURE AND THEORETICAL
FRAMEWORK
Overview
A review of the literature and theoretical framework for the research is presented in this
chapter. The review of literature focuses on barriers to effective ACP, patient-surrogate dyadic
congruence, and literature specific to patients with advanced cancer and ACP/EOL discussions.
The Respecting Choices® DS-ACP intervention, the intervention evaluated in this study, is
evaluated in terms of its implementations to date. The theory of representational approach to
patient education, which served as the theoretical basis to the Respecting Choices DS-ACP
intervention, is introduced.

Factors Considered Important at EOL
The literature about EOL has a number of foci, including factors considered most
important to those people who are eminently approaching EOL, the people who care for them,
and healthcare providers (Emanuel, Alpert, Baldwin, & Emanuel, 2000; Singer, Martin, &
Kelner, 1999; Steinhauser et al., 2000). The overarching conclusions from all these studies are
that support for decision making about EOL is essential and that this support must include
explicit communication about the difficult decisions patients and their surrogates are likely to
face and detailed information about patients’ wishes. This support and communication is to help
patients achieve a sense of control, thereby relieving burden on surrogates and strengthening
relationships between patients and surrogates. Although these studies were about EOL in
general, the same support requirements likely apply to ACP and EOL care for patients with lifelimiting cancer.
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EOL Treatment Decisions and Cancer Patients
Advance Directives
Written ADs in the form of living wills and appointments of health care surrogates allow
patients to communicate their wishes before they reach decisional incapacity. These documents
are intended to help patients with life-limiting illnesses avoid aggressive and futile life-sustaining
treatments.
Hospice and patient rights advocates identified the need for written ADs in the 1990s.
Since 1991, the federal Patient Self-Determination Act ([PSDA] 1990) requires Medicare and
Medicaid providers to inform all adult patients of their rights to prepare an AD, participate in and
direct their own health care decisions, accept or refuse treatment, and be informed of the health
care facility’s policy on the administration and application of these rights.
Despite widespread support for the concept of ADs, the potential benefits of written ADs
have not been actualized. According to Fagerlin and Schneider (2004), a number of conditions
must be satisfied for written ADs to function as intended. The first condition involves patients
completing an AD. Second, those individuals charged with making decisions for the patient (i.e.,
surrogates) must understand and be willing to follow the instructions written in the ADs.
These two seemingly facile tasks are more complicated than they appear to be. People
must decide in the present what treatment they would want in the future should they become
incompetent. The ADs must accurately state patients’ preferences in terms that are
understandable by medical teams and surrogates. Completed ADs must be made available to
individuals charged with making decisions for the patient. Concerns about the achievability of
these conditions have been echoed by many experts in EOL decision making (see, for example,
Ditto et al., 2001; Fagerlin & Schneider, 2004; Lo & Steinbrook, 2004; Perkins, 2007; Seckler,
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Meier, Mulvihill, & Paris, 1991; Teno, Lynn & Phillips, 1994; Teno et al., 1997; Teno, Nelson,
& Lynn, 1994). These concerns may account for why AD completion rates have remained low.
For example, a study that evaluated the frequency of use of ADs by critically ill cancer patients
at a tertiary cancer center found that this population of patients only had a 27% completion rate
(Kish et al., 2000).

Scope of Advance Care Planning
Completing an AD is part of a broader process of advance care planning (ACP). ACP
requires patients, surrogates, and providers to come together to develop a plan that meets the
patients’ goals, values, and preferences. Engaging in ACP early in the cancer care continuum is
especially important because delirium and other forms of cognitive impairment are prevalent
during treatment of advanced malignancies (Lynn, 2005; McCarthy et al. 2000; Morita, et al.,
2003).
Early efforts to improve cancer care communication through ACP focused on ADs that
primarily addressed resuscitation preferences. More recent efforts reflect the opinion that ACP
must be expanded beyond simple ADs. Planning for EOL has evolved from the goal of having a
patient complete ADs to engaging a patient in the process of thinking about what kind of lifeprolonging medical care he or she would want should the need arise. Additional components
include identifying a surrogate decision maker who will communicate the patient’s wishes if the
patient is unable to do so and helping the patient to communicate his or her wishes to the
surrogate (Levi, Dellasega, Whitehead, & Green, 2010). In short, although ACP may lead to
completion of ADs, its primary purpose is to facilitate the process of thinking about and
communicating wishes so that more informed care can be delivered at EOL.
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Role of Health Care Surrogates
One aspect of ACP involves delegating surrogates to make decisions on one’s behalf in
the event that one is no longer able to do so because of illness. Under the current U.S. model,
surrogates are instructed to provide substituted judgment, choosing what the patient would have
chosen based on the surrogate’s knowledge of the patient’s goals and values, the patient’s prior
behavior, or discussions with the patient about his or her preferences. If the patient never had the
decisional capacity or the patients’ preferences are unknown, a decision should be made in the
patients best interests (The President’s Council on Bioethics, 2005; Civil Rights Act, 2010).
There is emerging consensus against relying solely on substituted judgment or best interests
standards to judge the quality of a surrogate’s decisions (see for example, Fagerlin, Ditto, Danks,
Houts, & Smucker, 2001; Fagerlin & Schneider,2004; Fins et al., 2005; Shalowitz, GarrettMayer, & Wendler, 2006; Smucker et al., 2000; Sulmasy et al., 1998). In fact, many experts
challenge the ability of surrogates to use substituted judgment to accurately represent the
treatment preferences of patients (see for example, Fagerlin et al., 2001 Rosenfeld, Wenger, &
Kagawa-Singer, 2000; Shalowitz, Garrett-Mayer, & Wendler, 2006).

Inconsistency between ADs and Care Received
For patients with life-limiting cancer, the last six months of life are typically
characterized by functional decline, severe pain and confusion that could have been controlled
better by palliative care (Morita et al., 2003). Although patients increasingly prefer comfort care
as they near death, many die in pain (McCarthy et al., 2000) receiving aggressive cancer
treatment at EOL instead of palliation. In other words, they die receiving care that may actually
be unnecessary or harmful. Findings from the landmark Study to Understand Prognoses and
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Preferences for Outcomes and Risks of Treatments ([SUPPORT] The SUPPORT Principle
Investigators, 1995) showed that, among patients with colon and lung cancer, 40% were in
serious pain in the last days of life. More than 65% of these patients who died in serious pain
had stated a preference for comfort care (McCarthy et al., 2000). Furthermore, one in 10 patients
with lung and colon cancer received care that was incongruent with their preferences, as reported
by family members (Lynn, Harrell, Cohn, Wagner, & Connors, 1997).
Aggressive treatment of cancer, even among patients with poor prognosis, continues to
increase (Asola, Huhtala, & Holli, 2006; Earle et al., 2004; Goodman et al., 2010). The number
of claims submitted to Medicare for patients with advanced cancer indicated the percentage of
patients receiving chemotherapy within two weeks of death increased from 13.8% in 1993 to
18.5 % in 1996, and there were similar increases in numbers of emergency room visits and
intensive care unit stays (Earle et al., 2004). It should not be assumed these statistics reflect a
greater desire for aggressive care at EOL. In a study involving 335 patients with breast cancer,
at 2 months before death, 64% of patients continued to receive endocrine therapy and 20%
received chemotherapy, despite deterioration in their general condition. This situation is
contrary to the medical standard of care, which specifies that at about two months prior to death,
cancer-related treatment should be discontinued in favor of comfort measures (Asola et al.,
2006).
There is some evidence that continuing to receive aggressive treatment at EOL when the
AD states preferences for comfort measures may be particularly common in patients with lifelimiting cancer. In a study that prospectively compared resuscitation status for patients with
advanced cancer and patients with amyotrophic lateral sclerosis (ALS; Astrow et al., 2008), 6 of
the 24 patients with cancer with DNR orders were found to have received CPR, whereas none of
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the six patients with ALS with DNR orders received CPR. Because of the small numbers in the
study, the differences between the two groups were not statistically significant. Even so, these
numbers demonstrate the failure to honor cancer patients’ EOL wishes.

Barriers to Effective Advance Care Planning
Ineffective or Delayed Communication
For patients with life-limiting cancer, relevant medical intervention options typically
include short-term or terminal ventilator support, artificial nutrition and hydration, resuscitation,
and hospice care (Martin, Emanuel, & Singer, 2000). Informed decisions about EOL care require
a certain level of knowledge about these medical intervention options and their intended purpose.
Most cancer patients want to be informed if their illness is terminal and want information
about treatment options tailored for their individual needs (Hagerty, Butow, Ellis, Dimitry, &
Tattersall, 2005). Yet, ACP discussions may occur less frequently with this population than with
patients who have other life-limiting illnesses. A retrospective examination of charts of elderly
patients with advanced cancer found that only 38% had ACP discussions documented (Bradley
et al., 2001). A 2-year longitudinal study that involved reviewing medical records of 60 patients
with advanced cancer and 32 patients with ALS found that the rate of ACP discussions differed
in the two groups (Astrow et al., 2008). Although the patients with life-limiting cancer had
significantly poorer survival prognoses than did the patients with ALS, medical records indicated
that health care practitioners had far fewer ACP discussions with patients with life-limiting
cancer than they had with patients with ALS. Regardless of the reasons for this disparity,
patients with life-limiting cancer appear to be less adequately prepared for EOL decision making
(Astrow et al., 2008).
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The Astrow et al. (2008) study findings are consistent with a report that patients with lifelimiting cancer are not fully informed about palliative care as an alternative or supplement to
curative care (Gattellari, Voigt, Butow, & Tattersall, 2002). Similarly, a report on cancer care at
EOL published by the Dartmouth Atlas Project (Goodman et al., 2010) found that one in three
Medicare cancer patients spend their last days in hospitals and intensive care units. This finding
suggests that many clinical teams administer aggressive treatment with curative attempts the
patients may not want, negatively impacting their quality of their life in their last weeks and
months (Goodman et al., 2010).
Responsibility for hesitancy to discuss EOL issues has been attributed to ambivalence of
both the patient and the physician (Cherlin et al., 2005; Hagerty et al., 2005; Wright et al., 2008).
Although there is evidence that patients with life-limiting cancer want their health care
practitioners to initiate communications about ACP, providers rarely take the first step. Instead,
these health care professionals wait for their patients to raise the topic or initiate the conversation
(Baile, et al., 2002; Bradley et al., 2001; Walling et al., 2008).
Patient ambivalence is also reflected in a study by Lamont and Siegler (2000). They
found that patients with life-limiting cancer were willing to endorse a policy whereby medical
house staff discuss advance care preferences as part of the admission history. However, these
same patients did not want to have ACP discussions with their oncologist. Perhaps patients are
reluctant to initiate these discussions with their oncologists because of fears of being abandoned
as their illness progresses (Back et al., 2008). Another study clarified that patients with cancer
may be reluctant to discuss their advance care preferences with their oncologist but would do so
if the discussion was initiated by their oncologist (Dow et al., 2010). It is possible that although
patients with life-limiting cancer want to be involved in decisions about the care they will
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receive at EOL, they equate these discussions with being abandoned, particularly if they occur at
a time when the future becomes less certain (Quill & Cassel, 1995). Even if the evidence about
patients’ wanting these discussions with their oncologists is inconclusive, it is clear that patients
with life-limiting cancer want to know that they will receive quality care and support even if
curative treatments are ineffective (Evans, Tulsky, Back, & Arnold, 2006).
When advance care discussions do take place, studies suggest that clinicians do an
inadequate job communicating with patients and families. One area of inadequacy involves
providing relevant information in an understandable format (Bradley et al., 2001; Christakis &
Lamont, 2000). For example, Fried, Bradley, and O’Leary (2003) examined agreement between
patients or caregivers and providers regarding prognoses communication and found that,
although providers reported having informed the patient and/or caregiver of a life-threatening
condition, 46% of the patients and 34% of the caregivers reported no such discussion. In 23% of
patient/provider and 30% of caregiver/provider pairs, the provider reported discussing an
approximate life expectancy, whereas the patient or caregiver reported no such discussion.
Curtis, Patrick, Caldwell, and Collier (2000) found that one of the most frequently
identified barriers to communication about EOL care identified by 57 physicians and their
patients with AIDS was too little time during medical appointments. Lack of time is also a
barrier for oncologists. Baile et al. (2002) examined the attitudes and practices of 167 oncologists
regarding discussions of unfavorable medical information with their patients; the oncologists
reported lack of time as the most common barrier to communicating matters about EOL care.
Other commonly noted barriers included providers’ limited formal training, feelings of
unpreparedness, and the belief that conducting ACP discussions is complex (Tung, 2009;
Yedidia, 2007). Topics related to the need for training to engage in the complexities of ACP
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include fear of causing distress, helping patients make decisions for future treatment when
treatment options are unpredictable, helping surrogates understand patient choices, and timing
for ACP.

Fear of Causing Distress
ACP discussions require patients to confront the limitations of medical treatments and the
reality that life is finite, which can cause psychological distress (Quill, 2000). Research suggests
that both physicians and patients are ambivalent about talking about death and often avoid these
conversations (Back et al., 2008; Baile et al., 2002; Bradley et al., 2001; Hancock et al., 2007;
Kish et al., 2000). This ambivalence also extends to patients and their surrogates. Patients’ and
surrogates’ fears and concerns of emotional distress, not wanting to upset loved ones, and a
belief in positive thinking may prevent these dyads from discussing EOL issues with each other
(Zhang & Siminoff, 2003).
On the other hand, a systematic review of 46 studies suggests that most of these reported
fears are unfounded; patients and family members are capable of discussing EOL issues without
experiencing undue anxiety (Hancock et al., 2007). This conclusion is further substantiated by a
multisite, prospective, longitudinal cohort study of patients with advanced cancer and their
caregivers (Wright et al., 2008); 300 dyads were interviewed periodically from enrollment to the
patient’s death, which occurred approximately four months after the first interview. Within 2-3
weeks of the patients’ death, medical records were reviewed and caregivers were interviewed to
assess the patients’ quality of life near death. Bereaved caregivers’ psychiatric illnesses and
quality of life were assessed approximately six months after the patients’ death. There were no
group differences in patients’ and caregivers’ mental health among people who did and did not
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discuss EOL issues with providers. In other words, there was no evidence EOL discussions were
significantly associated with increased emotional distress or psychiatric disorders. Instead,
patients that did not have EOL discussion received significantly more aggressive medical care in
their final week of life, which was associated with worse patient quality of life near death
(Wright et al.).
Similar to the findings reported by Wright et al. (2008), receiving a patient-surrogate
ACP intervention (i.e., discussing and planning for EOL) did not result in increased anxiety for
members of the intervention group (Song et al., 2005). More specifically, there was no
significant difference in anxiety scores pre- and post intervention in the treatment and control
groups. Findings from these studies suggest that talking about EOL is not associated with
greater distress or anxiety (Hancock et al., 2007; Lyon et al., 2009; Song et al., 2005; Tang, Li, &
Chen, 2008). In fact, EOL discussions may result in increased patient understanding of illness
severity, fewer invasive procedures, lower rates of ICU admissions, and earlier hospice referrals
at EOL (Wright et al., 2008). In other words, avoiding EOL care planning may not be in the
patients’ best interest.

Inability to Predict Treatment Choices
Another potential barrier to ADs and traditional ACP includes patients’ inability to
predict their future treatment preferences because of the difficulty anticipating all of the
situations the patients may face (Fried et al., 2006; Fried & O’Leary, 2008; Teno et al., 1997;
Winzelberg, Hanson, & Tulsky, 2005). Patients or their surrogates may discover an AD created
during a period of relative health may not be applicable during a subsequent period of illness or
incapacity (Fried et al., 2006).
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Patients and surrogates often lack or misunderstand information about medical and
treatment options, and/or have inaccurate preconceptions about the nature of the decisions at
hand. For example, many people may be opposed to the notion of being placed on a ventilator,
but whether patients may be willing to endure mechanical ventilation likely will depend on the
reality of the circumstances (e.g., need for short- versus long-term mechanical ventilation, or
overall prognosis for recovery). Health care practitioners not only lack the time, but also the
skill needed to conduct in-depth discussions of EOL treatment decisions that consider key
circumstances or qualifying conditions (Cherlin et al., 2005; Tung, 2009; Yedidia, 2007).
Another reason for patients’ inability to predict future medical decisions is their over- or
underestimation of the impact that specific disabilities will have on their lives (Fried et al.,
2006). For example, patients may think they may be willing to accept losing the ability to walk
or talk, but not the loss of cognition. Their willingness may change once they actually begin to
lose the ability to walk or talk. In other words, patient preferences and the values underlying
those preferences may change over time and with experience. Caregivers, surrogates, and
patients’ health care providers may be challenged to make decisions that run counter to patients’
original AD, unless ACP addressed the possibility that preferences might change as the illness
progresses.

Surrogates’ Understanding of Preferences
Although patients may believe their ADs clearly express their preferences, these
preferences may be less clear to surrogates. First, patients’ expressed preferences for EOL often
do not apply to complex situations associated with life-limiting cancer. Second, surrogates may
also be challenged to make the “right” decision in cases where opposing goals and preferences
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must be balanced (see for example, Fried et al., 2009). For example, patients may communicate
conflicting information to the surrogate, stating they want to exhaust all possible measures to
prolong life but also want to be kept comfortable at the EOL.
These complexities may explain why having access to the patient’s AD or having a
conversation with the patient regarding EOL preferences has not resulted in congruence between
the patient wishes and the surrogate decision making (Coppola et al., 2001; Ditto et al., 2001;
Hare, Pratt, & Nelson, 1992; Hines et al., 2001; Marbella, Desbiens, Mueller-Rizner, & Layde,
1998; Ouslander, Tymchuk, & Rahbar, 1989; Shalowitz, Garrett-Mayer, & Wendler, 2006;
Uhlmann, Pearlman, & Cain, 1988; Zweibel & Cassel, 1989). For example, of the 250 patientsurrogate dyads interviewed by Hines et al. (2001), 63% of the patients and their surrogates
agreed the patient had informed the surrogate of his or her preferences, and 33% of the patients
reported having had more than five conversations with their surrogate. However, having more
conversations about EOL issues did not increase surrogates’ understanding of patients’ specific
preferences or values (Hines et al., 2001).

Timing
Patients with life-limiting illness and their caregivers and health practitioners have
disparate views about how, with whom, and when discussions about EOL issues should be
initiated (Clayton, Butow, Arnold, & Tattersall, 2005). Contrary to guidelines for providers to
discuss prognoses and realistic expectations with patients and their families (NCCN, 2010),
findings from a survey involving approximately 5,000 physicians indicated many physicians
delayed having EOL discussions until all nonpalliative treatments were exhausted or the patient
raised the subject (Keating et al., 2010).
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Research To Improve Patient-Surrogate Dyadic Congruence
When patients cannot exercise their autonomy over medical care, decisions must be made
for them on the basis of the substituted judgment standard. Most studies on this topic present
hypothetical scenarios and estimate concordance or percent agreement between the patient’s
stated preference for EOL care and the surrogate’s understanding of the patient preferences for
each scenario. Percent agreement represents how closely surrogates can approximate patient
decision making using substituted judgment.
Several studies have demonstrated that surrogate decision makers are not able to
represent the patients’ wishes accurately (Hare et al., 1992; Uhlmann et al., 1988; Zweibel &
Cassel, 1989). For example, Uhlmann et al. (1988) studied elderly outpatients to determine
spouses’ awareness of patients’ preferences for CPR or CPR plus ventilator following cardiac
arrest in context with varying prognoses and health conditions. Although more than 75% of the
spouses believed their predictions of patients’ preferences were accurate, accuracy did not
exceed that expected due to chance alone. Spouses significantly (p < 0.05) overestimated
patients’ preferences for resuscitation in the CPR and ventilation situations. These results
suggest that spouses often do not understand patients’ preferences and are unlikely to provide
congruent substituted judgment when faced with decisions about life-sustaining treatments.
A study conducted by Zweibel and Cassel (1989) examined the ability of physicianselected surrogates to use substituted judgment for older single or widowed patients by
examining a broader array of life-sustaining treatments than studied by Uhlmann and colleagues.
(Physicians typically select a family member to act as a surrogate decision maker when a patient
is older and single or widowed.) The study aims was to examine surrogates’ ability to accurately
reflect patient treatment choices when surrogates were not specifically directed to use substituted
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judgment. Fifty-five patient-surrogate dyads were separately presented with five hypothetical
case vignettes describing the following scenarios: CPR and mechanical ventilation for patients in
coma, receiving chemotherapy in end-stage cancer, patients’ inability to communicate with the
health care practitioner, amputation in a demented elderly man, and tube feeding of a woman
who refused to communicate with her doctors. For each scenario, surrogates were asked, “What
would you tell the doctor to do?” Differences in patient - surrogate pairs revealed opposing
decisions ranging from 24% for tube feedings up to 44% and 50 %, respectively, for
resuscitation and chemotherapy (Zweibel & Cassel, 1989).
Hare et al. (1992) used a method similar to that used by Zweibel and Cassel (1989) to
examine patients and their self-selected surrogates. However, they modified the vignettes used
by Zweibel and Cassel to address the possibility that the vignettes about tube feeding and
amputation were misinterpreted by study participants. The modifications included the following
contextual information: Patients’ current age was reported. Tube feeding was based a patient
who was in a permanent coma. Amputation was presented as a life-extending treatment and not
solely as a means of pain control. They also directed the surrogates participating in the study to
use a substituted judgment standard, choosing a treatment the patients would choose. The
sample included 50 patient-surrogate dyads with a range of ages, which allowed examination of
possible age differences in patient-surrogate decisions. As measured by the kappa coefficient
statistic, surrogates did not achieve statistically significant patient-surrogate dyadic congruence
for any of the treatment decisions (Hare et al., 1992). Similarly, when the preferences of elderly
patients in a nursing home facility were compared with their closest relative and nursing home
staff (i.e., a nurse, social worker, and physician), surrogates were found to not be significantly
better than chance at predicting patients’ treatment preferences (Ouslander et al., 1989).

23

Seckler et al. (1991) assessed dyadic congruence of 70 patient-family surrogate pairs
regarding the resuscitation preferences of competent elderly outpatients. They extended previous
work (Ouslander et al., 1989; Uhlmann et al., 1988; Zweibel & Cassel, 1989) by including an
assessment of the patients’ comprehension of the meaning of the hypothetical interventions they
were asked to consider. Patients were presented in person with three hypothetical CPR situations
under two health status circumstances: current health and moderate dementia. Family surrogates
were given the same situations and questionnaires over the phone. Though few pairs of patients
and surrogates had previously discussed medical care preferences, 87% of the patients predicted
that family members would accurately represent their wishes. Concordance between family
members and patients was statistically significant, but the obtained kappas (0.27 and 0.30,
respectively) indicated less than moderate strength of agreement (kappa > 0.4 is considered
moderate; Cohen, 1960). Moderate agreement should be the minimum percent agreement
required of surrogates when making serious EOL decisions on behalf of patients under the
substitute judgment standard.
One criticism of these studies (Hare et al., 1992; Seckler et al., 1991; Uhlmann et al.,
1988; Zweibel & Cassel, 1989) is that patients and surrogates were asked about patient
preferences when the patients were not critically ill. Asking about preferences for hypothetical
situations of deteriorating health that patients have yet to experience fails to characterize the
decisions of patients and surrogates who are actually facing serious and complex choices.
Research suggests that preferences for life-sustaining medical treatment can be unstable over
time and highly dependent on the specific situation (Fried et al., 2006; Hawkins, Ditto, Danks, &
Smucker, 2005). Because of the difficulty anticipating all of the situations patients may face
(Winzelberg et al., 2005), EOL decisions expressed during a period of relative health may not be
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applicable during a subsequent period of illness or incapacity (Fried et al., 2006). To investigate
if difficulty imagining a decline in health was a limitation, Layde et al. (1995) evaluated the
congruence of more than 1,000 patient-surrogate dyads when patients were hospitalized and
seriously ill. Because of the severity of patients’ illness and anticipated 6-month survival rate of
50%, Layde et al. were able to evaluate actual CPR preferences in light of the patients’ current
health status. Within pairs, the overall agreement rate with respect to CPR decisions was 74%.
For patients who did not want to be resuscitated, however, 50% of the surrogates did not reflect
the patient’s wishes.
There is some evidence indicating that surrogates who discuss patient preferences
beforehand have improved patient-surrogate dyadic congruence (Ouslander et al., 1989;
Sulmasy, Haller, & Terry, 1994; Sulmasy et al., 1998). A pilot study of 50 general medical
patients found that patient-surrogate dyadic congruence was positively associated with
discussion between patient and surrogates (Sulmasy et al., 1994). Building on this connection,
Sulmasy et al. (1998) conducted cross-sectional paired interviews with 250 patients with
terminal diagnoses and their surrogates to determine what factors are associated with higher
patient-surrogate dyadic congruence. On average, surrogates made correct predictions in only
66% of instances. Accuracy was higher for the permanent coma scenario than for scenarios of
severe dementia or coma with small chance of recovery (p = 0.001). The accuracy of substituted
judgments was positively associated with the patient having spoken with the surrogate about
EOL issues. Age, ethnicity, marital status, religion, and ADs were not associated with accuracy.
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Efforts to Improve Patient-Surrogate Communication
A number of intervention studies have evaluated how to increase patient-surrogate
communication to promote congruence so that surrogates adequately understand patients’
preferences to guide patients’ EOL treatment preferences. Interventions to improve patientsurrogate communication have included educational interventions, conducting values histories,
and having a trained facilitator engage both patients and surrogates in ACP.

Educational Interventions
Hare and Pratt (1993) evaluated the effectiveness of two educational programs: a
workshop delivered in a classroom (instruction style) and a home study program (written
materials). The objectives of the educational programs were to increase communication about
EOL decisions and to increase patient-surrogate dyadic congruence. Fifty patient-surrogate
dyads were presented with five hypothetical scenarios adapted from those used by Zweibel and
Cassel (1989). Prior to receiving the intervention, patients and surrogates were asked to
independently make treatment decisions based on what the patient would want for himself or
herself. Study participants self-selected to participate in either the evening workshop or the
home study. Participant reports about treatment decisions were obtained 6 weeks after each
program was completed. Participants who elected to attend the workshop had significantly
higher preintervention congruence scores compared to those who selected the home study
program. When age and preintervention scores were held as covariates, no significant
differences were found on the postintervention agreement scores according to form of
educational intervention. In addition, no significant difference in pre- and postintervention
agreement was found within groups. Overall, the educational workshop program appeared to
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have a somewhat more positive impact than did the home study program. Neither program,
however, significantly increased the agreement on difficult medical decisions (Hare & Pratt,
1993).
The SUPPORT initiative (The SUPPORT Principle Investigators, 1995) consisted of an
intervention designed to improve communication and ultimately agreement between patients and
their surrogates. A major hypothesis of SUPPORT was that accurate information and better
communication would decrease the frequency of unwanted life-sustaining treatments. The study
was conducted in two phases in five teaching hospitals. Phase I was a baseline observational
study, and Phase II was a block-randomized clinical trial of an intervention intended to improve
medical decision making and outcomes for seriously ill hospitalized patients (The SUPPORT
Principle Investigators, 1995). Using information gathered during Phase I, the investigators
developed an intervention to improve communication and understanding during the decisionmaking process and facilitate advance planning of treatment options. Nurses were trained to
assist and facilitate communication with the 2,652 patients who received the intervention. The
findings revealed a failure to honor patients’ EOL preferences. The design of SUPPORT served
as the baseline for several other investigations.
As an extension of SUPPORT (The SUPPORT Principal Investigators, 1995), Marbella
et al. (1998) investigated whether nurses who spent extra time with patient-surrogate dyads to
explain and answer questions about the patient’s prognoses and potential treatment increased
dyadic congruence about the patient’s treatment preferences. The treatment group included 386
dyads, and the control group was comprised of 331 dyads. No significant differences in dyadic
congruence were found between the two groups. Hiltunen, Medich, Chase, Peterson & Forrow
(1999) analyzed narratives written by SUPPORT nurses describing the difficult decisions
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seriously ill patients near the end of their lives face, and the experience of dealing with those
decisions. The burden and complexity of family decision making emerged as a major theme.
This analysis revealed that for successful ACP patients, families and providers should jointly
discuss the patient’s values and EOL wishes. Marbella et al.’s intervention may not have been
effective because it did not include a values history.

Values History and Facilitated ACP
A values history is a specialized AD form that allows a patient to clarify their healthrelated values and goals and communicate these values and goals to their surrogates. The
surrogate is then able to select treatment choices based on the patients’ values and goals. This
differs from a standard AD in that it asks patients to focus on clarifying their value- related
reasons for specific treatment choices (Doukas & McCullough, 1991).
Patients and surrogates also seem to agree about the benefit of a values discussion. The
utility of a values history is supported by a longitudinal study with 337 patient-surrogate dyads
that completed interviews and questionnaires. Over half of patients (57%) and surrogates (67%)
believed the best approach to documenting preferences was one that included both written
requests and verbal communications with surrogates. Of those who did not choose both methods,
more believed that verbal communication was the best approach. Most of the patients and
surrogates who desired a written request, (50% and 44%, respectively) preferred one that
contained only statements about values or goals (i.e., religious beliefs, importance of maintaining
cognitive functioning) for care that patients would want guiding medical decisions. Fewer
patients and surrogates desired an AD that included both value statements and precise treatment
direction, and fewer still preferred one that omitted value statements and included only precise
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directions regarding specific medical treatments (Hawkins et al., 2005). Similarly, in a
qualitative study, patients and surrogates reported that facilitated discussions that identified
values and discussions specific to health status or actual decisions that might need to be made
were more effective than a discussion about hypothetical situations without facilitation (Karel,
Powell, & Cantor, 2004).
Matheis-Kraft and Roberto (1997) conducted a randomized control trial to investigate
whether prior discussions between elderly female patients and their family member surrogates
were more effective if they included discussion of patients’ personal values. A list of 23 value
indicators and ten common EOL scenarios with three variations each (i.e., a total of 30 scenarios)
were used to stimulate discussions and prioritize values. The three variations for each of the ten
EOL scenarios were as follows: the patient’s current state of cognitive functioning, the patient as
permanently confused, and the patient in permanent coma. Patients in the experimental group
were asked to choose from the list of value indicators (i.e., independence, burden, dignity, fear,
comfort) that were most influential to her medical decision making and to discuss why the
selected value was important to her. The surrogate was instructed to consider the values that his
or her dyadic partner discussed. The experimental group did not have statistically higher
agreement than the control group in 27 of the 30 situations using kappa. Using percent
agreement, which is the best benchmark for assessing surrogates’ understanding of patient
preferences, the experimental group only had better patient-surrogate congruence in 11 of the 30
situations. Although the values history helped patients begin to communicate important
information for EOL planning, it was not sufficient (Matheis-Kraft & Roberto).
Another trial evaluating the benefit of including a values history also yielded
disappointing results. Ditto et al. (2001) tested various ADs with and without a values history as
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part of an investigation to determine whether discussing the AD with the surrogate increased
patient-surrogate dyadic congruence about patients’ EOL preferences. None of the interventions
produced significant improvement in congruence.
In contrast a study that included a trained facilitator in addition to a values history had
more promising results. This study was conducted in Spain and evaluated patient-surrogate
dyadic congruence in two intervention groups and in a control group; an AD containing a values
history, two educational sessions guided by a trained nurse or a control group who had neither an
AD nor participated in the educational sessions (Barrio-Cantalejo et al., 2009). Congruence in
the control group and the group without facilitation was comparable. However, congruence
between the dyads who received the facilitated educational sessions was significantly higher than
it was in the control or AD groups. This finding underscores the benefit of having a trained ACP
facilitator.
The promise of facilitated discussions between patients and surrogates that include
patient values has led to the focus more on ACP as a process during which patients explore,
discuss, articulate, and document their preferences rather than on ADs alone (Emanuel, von
Gunten, & Ferris, 2000). This new focus is also consistent with evidence that suggests that EOL
conversations should focus less on specific medical treatments a patient would or would not want
and more on aspects of the patient’s specific health status that are of particular importance to the
patient. For example, patients may be more concerned about pain, mental deterioration, or
physical dependency at EOL than whether they should be resuscitated (The President’s Council
on Bioethics, 2005). ACP that is customized to the patients’ health condition and guides patients
to express EOL wishes so that their surrogates are able to understand their values may be most
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effective (Bingley et al., 2006; Fried, Bullock, Iannone, and O’Leary, 2009; Matheis-Kraft &
Roberto, 1997; Rosenfeld et al., 2000).
In summary, if patients’ EOL wishes are to be honored, patient-surrogate dyadic
congruence must be improved. The relatively high rate of discrepant decisions between patients
and surrogates in the studies described above underscores the importance of effective patientsurrogate communication before the patient’s medical condition renders him or her unable to
make their treatment preferences known. Conclusions across studies that have explored
strategies to improve patient-surrogate dyadic congruence suggest that the most successful
interventions include the following components: patients and surrogates engage in a process of
exploring values and goals (Hawkins et al., 2005; Hiltunen et al., 1999; Sudore et al., 2008;
Sulmasy et al., 1994; Sulmasy et al., 1998); patients’ values and goals are explicitly
communicated to their surrogate (Barrio-Cantalego et al., 2009; Bingley et al., 2006; Hawkins et
al., 2005; Karel et al., 2004; Levi et al., 2010; Mathies-Kraft & Roberto, 1997; Rosenfeld et al.,
2000; Sulmasy et al., 1998), patient-surrogate discussions are facilitated by a trained professional
and are specific to the health problems patients with a particular illness are likely to encounter
(Barrio-Cantalego et al., 2009; Fried et al., 2009; Hagerty et al., 2005; Karel et al., 2004), and the
process occurs early and is modified as the patients’ illness progresses (Hiltunen et al., 1999;
Sulmasy et al., 1994; Sulmasy et al., 1998). The Respecting Choices® DS-ACP intervention
encompasses these strategies.

Respecting Choices® Disease Specific Advance Care Planning
Respecting Choices® DS-ACP is an interventional interview conducted with patients and
surrogates that is designed to promote the kind of in-depth dialogue central to ACP (Briggs &
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Hammes, 2008). The method by which Respecting Choice DS-ACP generates the AD document
(a Statement for Treatment Preferences) provides opportunities for accurate expression of the
patient’s wishes. Each element of the Respecting Choices DS-ACP interview is a venue for the
patient and surrogate to reflect on the patient’s goals and values and discuss how these goals and
values can direct treatment decisions. The final AD document is not only intended to help
patients communicate specific treatment preferences, but also to help surrogates understand
patients’ overarching priorities when unanticipated situations arise.
The Respecting Choices® DS-ACP has been evaluated for promoting patient-surrogate
congruence of shared decision-making outcomes and decisional conflict with patients with
chronic illnesses (Briggs et al., 2004), geriatric patients (Schwartz et al., 2002), and adolescents
with HIV (Lyon et al., 2009). All of these studies found the Respecting Choices DS-ACP
intervention significantly improved congruence between surrogates and patients in understanding
the patients’ preferences and reduced the surrogates’ decisional conflict. Respecting Choices
DS-ACP has also been evaluated in a multisite randomized controlled trial with outpatients
diagnosed with congestive heart failure or congestive respiratory failure (Kirchhoff et al., 2010)
and a randomized controlled trial study with 309 elderly hospitalized patients in Australia
(Detering, Hancock, Reade, & Silvester, 2010). In both studies, surrogates in the intervention
groups demonstrated a significantly higher degree of understanding of patients’ goals than did
surrogates in the control group (Detering et al., 2010; Kirchhoff et al., 2010). EOL wishes were
also respected significantly more in those who had died in the intervention group (25 of 29) than
those who had died in the control group (8 of 27; Detering et al., 2010).
A unique feature of Respecting Choices® DS-ACP is its focus on training professionals
in the communications skills needed to facilitate a discussion that engages patients and
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surrogates about the importance of ACP, the effects and meaning of the illness, and expectations
for future care (Briggs & Hammes, 2008; Briggs et al., 2004; Westley & Briggs, 2004). The
following components are included in the communication skill training: exploring past
experiences, fears, and concerns; clarifying medical information and disease complications;
assisting in weighing the benefits and burdens of life-sustaining interventions; and setting
guidelines on what it would mean to live well as health conditions change.
Respecting Choices® DS-ACP has not been evaluated in patients with life-limiting
cancer. Life-limiting cancer may present more complex EOL issues than the issues involved with
chronic illness or congestive heart or respiratory failure. Although Respecting Choices® DSACP is tailored to complications and life sustaining treatments that are specific to a given
disease, the same theoretical framework underlies every Respecting Choices® DS-ACP
intervention.

Theoretical Framework
The Respecting Choices DS-ACP intervention is based on the social science theory of the
representational approach to patient education (Donovan & Ward, 2001), which was derived
from elements of the common-sense model (Diefenbach & Leventhal, 1996; Ward, 1993). The
core tenet of the representational approach is that effective patient education is most likely to
occur when patients’ knowledge and beliefs are elicited before new information is provided
(Donovan & Ward; Diefenbach & Leventhal).
Donovan and Ward (2001) proposed that patients be given a representation of their
illness according to five dimensions: identity, cause, timeline, consequences, and cure/control.
Identity pertains to how a person describes and experiences his or her symptoms or health
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problem. Cause pertains to the individual’s beliefs about the origin of their health problem.
Timeline relates to beliefs about the length of the illness. Consequences are ideas about the shortand long-term outcomes of the problem. Cure or control are beliefs about the extent to which
one can control or cure a health problem.
According to Donovan and Ward (2001), the representational approach is a fluid
interview process that moves back and forth between these five dimensions. The goal of the
approach is to maximize opportunities for patients to reflect and comment on their own ideas
about their illness according to identity, cause, timeline, consequences and cure/control as well
as to provide new information about these illness dimensions when patients are most ready to
hear it. Opportunities for self-reflection provide conditions in which conceptual change can
occur throughout the entire process and provide patients with a cognitive framework for
interpreting and processing new information about their illness (Donovan et al., 2007).
Fins et al. (2005) and Maltby and Fins (2003) proposed a covenantal model of ACP
whereby patients with life-limiting cancer and their surrogates can explore complex EOL
situations that lack clear choices. A covenantal relationship between patient and surrogate is
sustained by trust and understanding. Trust and understanding can be the greatest sources of
guidance for surrogates facing EOL situations that are clinically and morally ambiguous and lack
clear choices, (Maltby & Fins).
Respecting Choices is designed to offer guidance and trust. The Respecting Choices®
DS-ACP requires developing or solidifying this covenantal relationship as part of helping both
patients and surrogates understand that complex situations may arise and necessitate an
interpretation of the patient’s judgment by the surrogate. The underlying premise is that
surrogates who have a reservoir of discretionary trust and receive adequate guidance from

34

patients are able to act ethically and effectively. An empowered surrogate is less likely to be
burdened by guilt and emotional pain that can result when making life and death decisions (Fins
et al., 2005).
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CHAPTER 3: METHODS
Research Design
The design for this study was a Phase I clinical trial. A Phase I clinical trial was selected
instead of a randomized control trial because of the risk of not providing an intervention that has
demonstrated benefits with other study populations. A Phase I clinical trial design is appropriate
for initial investigation of the impact of the Respecting Choices® ACP intervention with patients
with life-limiting cancer and their surrogates. Measures were administered before and after the
intervention. Anecdotal information was collected to evaluate patients’ and surrogates’
satisfaction with the intervention and its timing.

Independent and Dependent Variables
The independent variable in the study will be time (pre and post the Respecting Choices®
DS-ACP intervention). Dependent variables in the study will be patient-surrogate congruence,
patients’ anxiety, and decisional conflict.

Population, Sample, and Setting
The sample included patients and their surrogate decision makers who have received a
diagnosis of life-limiting cancer or whose previously treated cancer has progressed or
reoccurred. For the purpose of this study the term life-limiting cancer is defined as an initial or
recurrent diagnosis of advanced cancer or invasive cancer. Advanced cancer is cancer that has
grown beyond the organ in which it first started or affects a vital organ that cannot be removed.
Invasive cancer is when cancer cells have penetrated the original layer of tissue (ACS, 2010).
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Sample Selection
Eligibility and Exclusion Criteria
To qualify for inclusion in the study, both the patients and their surrogate decision
makers needed to be 21 years of age or older, speak and read English as their primary language
and have the capacity to understand the information on the Statement of Treatment Preferences
for Patients with Life-Limiting Cancer Form, a form which patients could choose to serve as
their AD if they participated in the study (see Statement of Treatment Preferences for LifeLimiting Cancer in Appendix A). Silberfeld, Nash, and Singer’s (1993) Verbal Assessment
Questions (Appendix B) were used to screen for participants’ capacity to understand the nature
and purpose of the Statement of Treatment Preferences for Life-Limiting Cancer Form and the
role of health care surrogates. The principal researcher administered the questions verbally prior
to the intervention. The patients were required to assign a surrogate who would participate with
the patient in the Respecting Choices® DS-ACP intervention. The surrogate could be a friend, a
relative, or other known person who agreed to perform the role of surrogate. Participants were
excluded from the study if they did not have a surrogate who was willing to participate in the
intervention.

Recruitment
The initial intent was to recruit participants through partnership with area oncologists.
However, consistent with the literature (see for example, Astrow et al., 2008; Baile, et al., 2002;
Bradley et al., 2001; Curtis et al.,2000; Kish et al., 2000; Tung, 2009; Walling et al., 2008;
Yedidia, 2007), it was difficult to gain consent from practicing health care professionals. More
specifically, over fifteen local practices were contacted, including oncologists, primary care,
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internal medicine, and hospice. Only one of these contacts led to a referral to potential study
participants. Additional networking led to the Volunteers in Medicine Clinic (VIM), who eagerly
embraced the opportunity to provide this ACP intervention to patients under their care who were
dealing with life limiting cancer. The VIM clinic serves the health and wellness needs of
community members who are not eligible for any government programs, are not covered by
insurance and have income below 200 per cent of the poverty level. Medical care is provided by
volunteer medical personnel working in concert with existing medical resources in the
community, including oncologists and cancer centers.
The Health Insurance Portability and Accountability Act (HIPAA) precludes the
researcher from screening or directly approaching potentially eligible patients. Therefore, the
researcher presented selected VIM referral providers with inclusion and exclusion criteria and a
verbal script to ask patients who met the eligibility criteria if they were interested in receiving
additional information about the study. If a patient was interested in obtaining additional
information, he or she was given a copy of an introductory letter written by the researcher that
described the study (Appendix C). Interested patients who agreed to be contacted provided their
preferred contact information on a card that accompanied the introductory letter.
The researcher contacted the potential participant(s) via their requested method,
explained the study, confirmed that the patient had a surrogate decision maker, and explained the
informed consent procedure. If the potential participant(s) agreed to participate, a meeting was
scheduled to obtain informed consent (see Informed Consent and Appendix D), and enroll the
patient and the surrogate. Study participation occurred at this same appointment, following
consent. Special attention was given to ensure that participation was completely voluntary. In
other words, that all contact with potential study participants was free of coercion and undue
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influences (National Institutes of Health [NIH] 1979). Potential participants were assured that
participation was completely their choice and that not participating would in no way affect their
care. Potential participants who self-reported being uncomfortable with or not being ready to
participate in the Respecting Choices intervention were provided with contact information in the
event that they changed their mind or wanted more information.
Although 12 eligible participants from VIM initially agreed to participate in this ACP
intervention, only five were able to do so due to the severity of their life limiting cancer.
However, snowball recruitment provided an additional nine eligible recruits for the intervention.
Three of the five participants who were recruited from VIM and received the intervention
referred people with life-limiting cancer based on their satisfaction with the intervention.
Participants referred by participants from VIM also provided referrals, including patients they
met in cancer support groups or during treatment, for example during infusion therapy sessions.
These potential participants were given the introductory letter (Appendix C) by the person
referring them to the study. Interested individuals who agreed to be contacted gave verbal
consent to their referral source and provided their preferred contact information on a card that
accompanied the introductory letter. After receiving permission, the investigator contacted
potential participants and followed the recruitment and informed consent sequence as previously
described.

Sample Size, Power, and Significance
The initial plan was a sample size ranging from 15-34 depending on effect size. The
upper number, 34 dyads, was based on detecting a medium effect size of .50, assuming a power
of .80, and an  of .05 in analyses involving the paired t-test (Faul, Erdfelder, Buchner & Lang,
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2009). However, analyses were conducted once data were obtained from 15 dyads to determine
if the study effect sizes were large enough (.80) to be detected with a smaller sample.
Recruitment ceased once it was determined that 15 dyads provided sufficient power (.80) to
detect a significant effect.

Setting
The setting for the proposed study was at the VIM clinic or the participant’s home.
Participant(s) were asked to select the time and location that they preferred.

Ethical Considerations
Based on findings from numerous studies with other study populations, (Briggs et al.,
2004; Detering et al., 2010; Kirchhoff et al.,2010; Lyons et al., 2009; Schwartz et al., 2002; Song
et al., 2005), there is strong evidence that the Respecting Choices® DS-ACP intervention is
superior to traditional approaches for AD completion. Thus, all participants in this study received
the intervention. Delivering the intervention to everyone was based on two principles--the
wellbeing of each individual research participant taking precedence over all other interests and
access to the best available standard of care (World Medical Association, 2008)-In addition to following procedures for informed consent (see below), special attention
was given to the sensitive nature of discussing EOL issues with patients and their surrogates.
Extra attention was given to providing patients and surrogates with adequate study information
to support making an informed decision about study participation. The guidelines outlined in
Eligibility and Exclusion Criteria to assess the capacity to participate in the intervention and
complete the AD were followed to decrease potential misunderstandings about the intervention
and study procedures. Situations that might cause distress or burden were carefully considered
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and managed during the intervention (NIH, 1979; McMillan & Weitzner, 2003). For example,
the intervention includes a step to ensure that specific questions or concerns that arise during the
intervention are discussed with the study participant and, if needed and with participant’s
permission, referred to the individual’s health care provider (see Stage 6 of the intervention in
Respecting Choices® DS-ACP Interview and Appendix E). Procedures were in place in the
event additional resources were identified during the interview.
Additionally, data collection and the intervention were designed to minimize risks and
burden. The intervention was scheduled to occur at a time and place that was most convenient
for the participants. All data collection instruments were selected to collect only essential data
and were administered at one visit by one researcher to ensure consistent application of the
instruments.

Informed Consent
Participants were provided with a description of the study, its purpose, and why they
were selected. The participants were given a description of what they would be asked to do, how
long it would take, and information about the potential risks and benefits of participating. They
were provided with a statement that participation was completely voluntary and that they could
withdraw at any time without repercussions. Participants were provided with the researcher’s
contact information and instructed to contact her if any questions were to arise before or during
the study. The participants were also provided with a name and contact information of another
person they could call if they have any complaints or concerns about the research. A copy of the
informed consent form and its explanatory text are included in Appendix D.
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A copy of the Statement for Treatment Preference For Life-Limiting Cancer Form (see
Appendix A) was given to the participants for their records. No names or identifying
information were written on the data collection forms. Instead, the names of patients and
surrogates were replaced by numbers randomly assigned to each dyad. Only one person, the
researcher conducting the study, collected and stored the data. The participants were assured that
all data would be kept confidential.
Permission to proceed was sought and secured from the Institutional Review Board (IRB)
associated with the proposed research. The investigator first secured approval to proceed from
the University of Central Florida’s IRB before launching the study.

Intervention
Respecting Choices® DS-ACP Interview
The Respecting Choices intervention is delivered as a one-time interview that provides a
structured approach for assessing the patient’s and his or her surrogate’s representation of the
patient’s illness, beliefs, goals, and values. The interview also explores experiences that may
have an impact on health care decision making. The intended goal of this intervention is to help
patients make informed choices that are understood by the surrogate. In the event there is a need
for an additional meeting or follow-up discussion after the patient speaks with their healthcare
provider, a follow up meeting is scheduled.
The six key stages of the Respecting Choices interview are as follows: (1) assess illness
beliefs, goals, and values; (2) explore experiences; (3) explain the purpose of advance care
planning; (4) clarify goals for life-sustaining preferences; (5) summarize what was learned; and
(6) develop a follow-up plan. Details on these six stages are provided in Respecting Choices®
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DS-ACP Interview (see Appendix E). The interview takes approximately 90 minutes. The
researcher is a trained Respecting Choices ACP facilitator and delivered the intervention. The
researcher took brief handwritten notes during the intervention to develop a follow-up plan for
participants. The researcher documented anecdotal information as field notes after each
interview.
Respecting Choices® DS ACP is a standard intervention with protocols that were applied
consistently in a predetermined sequence. Fidelity to the intervention was maintained by its
being administered by one trained facilitator. Any deviation to protocol that occurred was
documented in a study log. The only deviation to protocol pertained to the recruitment method as
described above (see Recruitment).
The Respecting Choices® DS ACP intervention uses disease specific scenarios and these
scenarios are integrated into the Statement of Treatment Preferences Form (see Appendix A).
Development of these scenarios was guided by the research of Fried et al. (2002), who noted that
the treatment decisions of people with life-limiting illness are influenced by treatment burden,
treatment outcome, and the likelihood of the outcome. Patients are asked to verbalize their goals
for life sustaining treatments in clinical scenarios that include the following: low survival but
high burden; high survival with functional disability; and high survival with cognitive disability
specific to the illness trajectory of life-limiting cancer.

Respecting Choices Facilitator Training
Health care professionals who wish to administer the Respecting Choices® DS-ACP
intervention materials are required to complete training. The training incorporates Weiner and
Cole’s (2004) conceptual approach, which addresses specialized skills of shared decision making
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specific to advanced illness and EOL in addition to general patient-centered communication
skills. Facilitators learn key communication techniques, such as exploring the meaning of words
and phrases, listening, paraphrasing, clarifying, affirming and reaffirming, and displaying
empathy. These communication techniques are integrated into the delivery of the Respecting
Choices intervention and allow for the following: in-depth expression by the patient and
surrogate; increasing patient and surrogate knowledge of the patient’s illness; clarifying the
patient’s goals, values, and beliefs, thereby informing the surrogate; creating shared decision
making as an approach; and creating an environment of trust and openness (Briggs & Hammes,
2008/2010).
The researcher completed the Respecting Choices facilitator training program in
February, 2010. In addition to instruction in communication techniques, the 2-day competencybased training program included online learning modules, review of relevant literature,
demonstrations, and practice scenarios to support the achievement of expected outcomes. The
training also included the researcher demonstrating delivery of the Respecting Choices® DSACP interview via videotaping a role play and receiving constructive feedback from Respecting
Choices faculty (Briggs & Hammes, 2008). As a final step in the ACP facilitator training
protocol, the researcher completed and submitted a second video role-play for evaluation prior to
administering the intervention for this proposed study. This final step culminated in certification
and was completed prior to beginning recruitment of participants.
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Instruments
Sociodemographic Form
Two versions of a sociodemographic questionnaire were administered: one for the patient
and one for the surrogate (see Appendix F). Both versions include age, gender, marital status,
education level, income, religious affiliation, and patient-surrogate relationship. The patient
form also includes diagnosis, referral source (e.g., VIM Clinic, friend), housing status (where
and with whom the patient lives), and a question about the patient’s perceived prognosis. The
surrogate form also includes a question about the surrogate’s perception of the patient’s
perceived prognosis

Statement of Treatment Preferences for Life-limiting Cancer
The Statement of Treatment Preferences for Life-Limiting Cancer Form (see Appendix
A) presents five clinical situations and clarifies goals for the patient’s preferences and assesses
the surrogate’s understanding of the patient’s preferences in each of the clinical situations. The
first four clinical situations describe the following cancer outcomes after a trial of treatment: a
prolonged hospital stay with little chance of survival; a worsening of the cancer with a 2-3 month
survival; a good chance of survival with functional impairment requiring 24-hour nursing care;
and a good chance of survival with permanent cognitive impairment requiring 24-hour nursing
care, respectively. The fifth situation requires CPR and has a poor outcome. After discussion and
clarification of the meaning of each situation, the patient is asked to choose 1 of 2 options for
each situation: “continue all treatment,” or “stop all treatment.”
The Statement of Treatment Preferences was developed by Briggs & Hammes
(2008/2010) and pilot tested with patients to assess participants’ understanding of the form prior
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to its use in research settings (Hammes, 2001). It has been used in research settings as a decision
aid and documentation tool to promote understanding of likely situations that could occur in the
future and express the patients’ goals of treatment in light of acceptable and unacceptable
burdens and outcomes (Briggs et al., 2004; Detering et al., 2010; Kirchhoff et al., 2010; Lyons et
al., 2009; Schwartz et al., 2002; Song et al., 2005).
The Statement of Treatment Preferences is based on a modified version of the Emmanuel
and Emmanuel Medical Directive, a reliable and valid means of both documenting patient wishes
for EOL care and measuring the outcome of ACP interventions (Schwartz, Merriman, Reed &
Hammes, 2004). Reliability assessment included internal consistency reliability across situations
within and across treatments and situations and test-retest stability among patients with stable
health (Schwartz et al., 2004). Both types of reliability were high.

Decisional Conflict Scale
The DCS (see Appendix G) measures perception of uncertainty in choosing medical
treatment options and factors contributing to uncertainty, such as lack of information, lack of
clarity regarding personal values, and lack of support in decision making (O’Connor, 1995,
updated 2005). This instrument consists of 16 items and the following five subscales: Informed
subscale (items 1-3), Values Clarity subscale (items 4-6), Support subscale (items 7-9),
Uncertainty subscale (items 10-12), and Effective Decision subscale (items 13-16). Items in
each subscale are scored on a 5-point Likert-type scale from 0 (strongly agree) to 4 (strongly
disagree). The DCS was designed to be self-administered.
The DCS has been widely used to evaluate patients’ decisions regarding types of health
care treatment (O’Connor, 1995). Cronbach’s alpha for the total DCS ranged from 0.78 to 0.92
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(Meropol et al., 2003; O’Connor et al., 1999; O’Connor & Jacobsen, 2007). This instrument has
been shown to have clinical utility, especially in situations in which patients are faced with
complicated decisions. Sample size in most studies is usually based on detecting effect size of
0.30-0.40. Scores lower than 25 are associated with implementing decisions; scores exceeding
37.5 are associated with decisional delay or feeling unsure about implementation (Graham &
O’Connor, 1995, updated 2005).
Song and Sereika (2006) examined the reliability and the validity of the DCS when the
tool was used to measure patients’ evaluations of the EOL decision-making process. This
evaluation used a combined sample of patients who had participated in two previous studies
(Briggs et al., 2004; Song et al., 2005). Song and Sereika, with one exception, found the DCS to
have acceptable reliability and validity when used to assess EOL decision making. The
exception pertained to the weak relationship between the uncertainty subscale and perceptions of
the modifiable factors contributing to uncertainty, such as ‘feeling the decision is easy to make’.
They concluded that uncertainty is not a useful domain to measure when uncertainty is
inevitable. Therefore, the original plan was not to use the uncertainty subscale (items 10, 11, and
12) in this study. However, most of the obtained inter-item correlation among the Uncertainty
items was higher than .30. Thus the Uncertainty subscale was included in this study.

Spielberger State Anxiety Scale S-anxiety Scale
The STAI is comprised of two separate self-report scales for measuring state and trait
anxiety, but only the scale for State anxiety was used in this study (see Appendix G). The Stateanxiety Scale (STAI Form Y-1) consists of 20 statements that evaluate the respondent’s feelings
of apprehension, tension, nervousness, and worry right now—at the moment (Spielberger, 1983).
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The STAI (Form Y-1 & Form Y-2) was designed to be self-administered and is reported to take
approximately 6 minutes when used with college students and approximately 10 minutes when
used with less-educated or emotionally disturbed persons (Spielberger, 1983).
The S-anxiety Scale has been found to be a sensitive indicator of change in transitory
anxiety experienced by clients and patients in counseling, psychotherapy, and behavior
modification programs. The scale has also been used extensively to assess S-anxiety induced by
stressful experimental procedures and unavoidable real life stressors (Spielberger, 1983).
In studies conducted by Spielberger (1983), the stability coefficients for Form Y-1 were
based on two groups of high school students tested in classroom settings. Test-retest intervals
were 30 days (0.62 for males, 0.34 for females) and 60 days (0.51 for males, 0.36 for females).
As would be expected for measures assessing change in anxiety resulting from situational stress,
stability, as measured by test-retest coefficients, was low for the S-anxiety Scale. Internal
consistency reliability ranged from 0.83-0.92 for S-Anxiety Scale (Weintraub & Hagopian,
1990).
Concurrent validity was supported by correlating the STAI with the Taylor Manifest
Anxiety Scale and Institute for Personality and Ability Testing (IPAT) Anxiety Scale (0.79 to
0.83 and 0.75 to 0.76, respectively). Construct validity was determined by comparing like
subjects under stressful and nonstressful situations (Derogatis & Wise, 1989). The STAI has
been successfully used with high school and college students (Gaudry, Vagg & Spielberger,
1975; Spielberger, 1983), psychiatric patients (Spielberger 1983), medical and surgical patients
(Cupples, 1991; Petersen, 1991; Weintraub & Hagopian, 1990; Wong & Bramwell, 1992;
Zimmerman, Pierson, & Marker, 1988), obstetric patients (Annie & Groer, 1991; Pond & Kemp,
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1992), the chronically ill (Gift, 1991), and the elderly (Fraser & Kerr, 1993). The STAI is
written at a fifth-grade level.
Complete instructions are printed on the test form but may be modified to evaluate the
intensity of the S-anxiety for any situation or time interval of interest. For research purposes, the
researcher can alter instructions for the S-anxiety Scale to focus on a particular time period
(Spielberger, 1983). In this study, the specified time period was “right now.”
To reduce response bias, such as the tendency to agree with positively worded items, half
of the items are stated positively and half are stated negatively. The scoring weights for the
anxiety-absent items are reversed (see Appendix H). Each STAI item is given a weighted score
of 1 to 4. A rating of 4 indicates the presence of a high anxiety level for 10 items and a high
rating indicates an absence of anxiety for the remaining 10 items. The scoring weights for the
anxiety-absent items are reversed (for example, items marked 1, 2, 3, or 4 are scored 4, 3, 2, and
1, respectively). The anxiety-absent items for which scoring is reversed on the S-anxiety Scale
are 1, 2, 5, 8, 10, 11, 15, 16, 19, and 20. To obtain scores, the weighted scores for 20 items are
added together, taking into account the fact that scores are reversed for these items. Scores can
vary from a minimum of 20 to a maximum of 80 (Spielberger, 1983).

Quality of Communication about End-of-life Care
The Quality of Communication about EOL Care Form (see Appendix I) assesses the
fidelity of the intervention by asking about patient and surrogate satisfaction with the overall
quality of the intervention and the facilitator. The form has been utilized to evaluate the quality
of communication regarding EOL treatment in studies between the patient and his or her health
care provider and the patient and nurse providing the Respecting Choices® ACP interview
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(Briggs et al., 2004; Curtis, Patrick, Caldwell, Greenlee, & Collier, 1999; Lyons, et al., 2009;
Song et al., 2005). This instrument consists of five questions: The first question asks if the
patients’ treatment preferences are known (congruence). Question 2, 3 and 4 pertain to whether
participants felt the interviewer truly cared about them, listened, and gave them enough attention
during the discussion (interviewer fidelity). These four questions are rated on a scale of 1 (no) to
3 (definitely yes). The fifth question asks participants to rate the overall quality of the discussion
(interview fidelity) on a scale of 1 (poor) to 5 (excellent). Use of this questionnaire among AIDS
patients has yielded good internal consistency with a Cronbach’s alpha of 0.81 (Curtis et al.,
1999). In a study using the Respecting Choices® ACP intervention, the internal consistency
reliability was 0.87 (Song & Sereika, 2006).

Data Collection Procedure
After IRB approval was received from the researcher’s university and referral sources, all
eligible patient-surrogate dyads referred for study participation were provided with information
about informed consent and requested to consent to participate (see Appendix D). Participants
who agreed to participate signed the informed consent form, a copy of which was returned to
both members of the dyad and the original retained by the researcher. Based on
recommendations from prior studies (Ditto et al., 2001; Schwartz et al., 2002) in which
transportation was a barrier to participating, participants were offered the choice of their home as
the site of data collection. Each patient-surrogate dyad was scheduled for one 90-minute
Respecting Choices® DS-ACP interview by the researcher. Prior to the interview, both the
patient and surrogate were separated and requested to independently complete the appropriate
Sociodemographic Data Form (see Appendix F), and Statement of Treatment Preferences for
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Life-Limiting Cancer Form (see Appendix A). Patients also completed the DCS (see Appendix
G) and STAI (see Appendix H). Participants were instructed to respond according to how they
felt immediately before the intervention.
Next, the patient-surrogate dyads participated in the Respecting Choices® DS-ACP
interview. The six stages (see Respecting Choices DS- ACP Interview in Appendix E) were
addressed in one 90-minute interview session. Immediately after the interview, the patient and
surrogate were separated. The patient completed the STAI second time (post test) but this time
the directions were to respond based on how he or she felt immediately after the intervention.
After completing the second administration of the STAI, the patient was also asked to complete
the Statement of Treatment Preference for Life-Limiting Cancer Form, the DCS and the Quality
of Communication about EOL Care Form. The surrogate also completed the Statement of
Treatment for Life-Limiting Cancer Form and the Quality of Communication about EOL Care
Form (see Table 1). Participants were asked to write in a response to an additional question about
whether they thought this was a good time to have this discussion. Some participants chose to
write qualifying information about the best possible time.
All forms were collected and stored by this researcher, as described in the section on
Ethical Considerations. The patient’s Statement of Treatment Preferences for Life-Limiting
Cancer, as well as any written information about concerns or questions collected during the
interview (e.g., questions the patient would like to discuss with his or her health care provider)
were given to the patient.
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Table 1. Data Collection Method by Time Pre-and Post- Intervention (Patients, Surrogate)

Patient

Surrogate

Pre Intervention

Post Intervention

Demographic Form (patient version)
Statement of Treatment Preferences
DCS
STAI

STAI
Statement of Treatment Preferences
DCS
Quality of Communication Form

Demographic Form (surrogate version) Statement of Treatment Preferences
Statement of Treatment Preferences
Quality of Communication Form

Data Analysis Plan
Data were entered into SPSS version 18.0 for Windows for analysis. Descriptive
statistics were performed to describe the sample and included the frequencies and percentages,
means, and standard deviations. For categorical or nominal data, frequencies and percentages
were conducted. Means and standard deviations were calculated on interval/ratio data (Cronk,
2006; Salkind, 2005).

Research Question 1
RQ1: Does the intervention increase congruence on the Treatment Preferences for LifeLimiting Cancer Form (pretest versus posttest) between patient and matched surrogate?
To answer RQ 1, five 2x2 McNemar Chi-square tests were conducted to investigate
whether the intervention increased congruence on the statement of treatment preferences for lifelimiting cancer form (pretest versus posttest) between patient and matched surrogate. A pretest
agree/disagree (0, 1) score and a posttest agree/disagree (0, 1) score were calculated for each
patient-surrogate pair for each of the five situations. One McNemar Chi-square analysis was
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conducted for each situation to compare changes in patient-surrogate agreement pre and post
intervention. The rows correspond to pretest congruence (disagreement, agreement) and the
columns correspond to posttest congruence (disagreement, agreement). A significant McNemar
Chi-square test was interpreted as a significant change in the proportion of congruence over time.

Research Question 2
RQ2: Are there significant differences in the proportion of congruence observed for
different situations at post test?
To answer RQ 2, the Zar’s Multiple Comparison Test of Differences was conducted to
investigate whether there are significant differences in the proportion of congruence observed for
different situations on the Statement of Treatment Preferences for life-limiting cancer form at
post test.

Research Questions 3 and 4
RQ3: Does the intervention reduce patients’ decisional conflict?
RQ4: Does the intervention increase patients’ anxiety?
A paired-sample t test was conducted to address both research questions 3 and 4. The
independent or grouping variable in both analyses was time (pretest versus posttest). The pairedsample t test is an appropriate statistical analysis when the two scores are repeated measures,
such as in situations when the assessment is used as a pretest before an intervention and as a
posttest after the intervention (Field, 2005). The dependent variable in each analysis (decisional
conflict, anxiety) was evaluated for presence of outliers and problems with normality prior to
conducting the t-test. Descriptive statistics (skew, frequency) were inspected to evaluate
normality. All appropriate assumptions were met for analysis using the paired-sample t test.
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Analysis Assessing Fidelity and Timing of Intervention
Frequencies and percentages were conducted for the five items on the Quality of
Communication about EOL Care Form to assess the fidelity of the intervention. “Yes” and “No”
responses to the additional question about timing were tallied. Anecdotal comments about timing
were content analyzed and summarized.
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CHAPTER 4: RESULTS
Descriptive Statistics
Sample
Thirty people participated in the study, 15 patients and 15 paired surrogates. Although 12
eligible participants from VIM initially agreed to participate in this ACP intervention, only five
were able to do so due to the severity of their cancer and/or reluctance to add to their surrogates’
burden. As previously discussed (see Recruitment), snowball recruitment provided an additional
nine eligible recruits for the intervention.
The demographic characteristics of the sample are presented in Table 2. All but three
patients reported employment status as ‘not currently working due to their current illness’ or
‘retired.’ As can be seen in Table 2, slightly more than half of the participants were 55 years of
age or older (n = 8, 53.3%) and the majority of surrogates were younger than the patients (n = 9,
60.0%). The majority of surrogates were spouses of married patients (n=9, 60%); a spouse was
the surrogate for all but one of the nine married patients (n = 8, 90%). All patients reported some
category of Christian as their religious background and almost half reported attending religious
services at least once a month (n=6, 40%). Many participants were reluctant to report income but
the five who were recruited from VIM were at least 200% below the poverty level.
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Table 2. Socio-Demographic Characteristics
Patient
Demographic

Surrogate

n

%

n

%

54 years old or younger

3

20.0

9

60.0

55-59 years old

8

53.3

3

20.0

60 years old or older

4

26.7

3

20.0

Male

6

40.0

3

20.0

Female

9

60.0

12

80.0

Single

-

-

1

6.7

Married

9

60.0

13

86.7

Divorced

5

33.3

-

-

Widowed

1

6.7

-

-

Domestic partnership

-

-

1

6.7

Non-denominational Christian

10

66.7

8

53.3

Catholic

5

33.3

7

46.7

4

26.7

1

7.1

Age

Gender

Marital status

Religious Affiliation current

How Often Attending Religious Services
Once a week or more
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Patient
Demographic

Surrogate

n

%

n

%

About once a month

2

13.3

5

35.7

Holy days and special occasions only

2

13.3

6

42.9

Never

3

20.0

1

7.1

15

100

-

-

High school diploma/GED

3

20.0

2

14.3

Associates degree

8

53.4

4

28.6

Bachelor’s degree

2

13.3

5

35.7

Graduate degree

2

13.3

1

7.1

Breast

5

35.7

-

-

Lung, Testicular

1

7.1

-

-

Multiple myeloma

1

7.1

-

-

Mouth, Tongue

1

7.1

-

-

Prostate

2

14.2

-

-

Nonhodgkins lymphoma

1

7.1

Ovarian

1

7.1

Kidney

1

7.1

Patient Housing Status
Home
Education Level

Patient Cancer Diagnosis
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Patient
Demographic

Surrogate

n

%

n

%

Spouse

-

-

8

53.3

Child

-

-

3

20.0

Friend

-

-

4

26.7

VIM

5

33.3

-

-

Urologist

1

6.7

-

-

From a Study Participant

9

60.0

-

-

Not Currently Employed

12

80.0

Currently Employed

3

20.0

Surrogate Relationship

How patients were referred to study

Employment

Research Question 1
RQ1: Does the intervention increase congruence in reported Treatment Preferences for
Life-Limiting Cancer Form (pretest versus posttest) between patient and matched surrogate?
Congruence between patient and matched surrogate for treatment preferences for lifelimiting cancer significantly increased from pretest to posttest in situations 1, 3 and 5, (low
survival, high burden; high survival, functional disability; and CPR, high burden, respectively).
The remaining situations 2 and 4 (poor outcome, high burden and high survival, cognitive
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disability, respectively) had complete agreement at the posttest so that the binomial test was
required rather than the McNemar test. Table 3 presents the results by situation.

Table 3. Results for McNemar and Binomial Tests for Congruence at Pretest and Posttest
Situation

Pretest Agreement

Posttest Agreement

p

1 – low survival, high burden

53.3 (n=8)

93.3 (n=14)

.031

2 – poor outcome, high burden

60.0 (n=9)

100.0 (n=15)

.001a

3 – high survival, functional disability

26.7 (n=4)

93.3 (n=14)

.002

4 – high survival, cognitive disability

66.7 (n=10)

100.0 (n=15)

.002 a

5 – CPR, high burden

40.0 (n=6)

93.3 (n=14)

.008

Note. a Binomial tests used due to 100 % agreement at posttest.

Research Question 2
RQ2: Are there significant differences in the proportion of congruence observed for
different situations at posttest?
The proportion of congruence observed after the intervention did not differ across the
five situations (p ≥ 0.50). These proportion ranged from 93 % - 100% (see Table 3)
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Table 4. Zar’s Multiple Comparison Test of Differences in Proportions of Congruence across
Situation at Post-test
Proportions

p’

1 – low survival, high burden

14/15

77.47

2 – poor outcome, high burden

15/15

84.85

3 – high survival, functional disability

14/15

77.47

4 – high survival, cognitive disability

15/15

84.85

5 – CPR, high burden

14/15

77.47

Situations

Research Question 3
Does the intervention reduce patients’ decisional conflict?
To examine research question 3, a paired sample t-test was conducted to assess if there
were significant differences in decisional conflict scale (DCS) over time (pretest vs. posttest).
The results of the dependent sample t - test were significant, t (14) =4.49, p < .001, suggesting
that posttest decisional conflict was significantly reduced (see Table 5).

Table 5. Results of Paired Sample t Test for DCS Scores by Time (Pretest vs. Posttest)

DCS

Pretest M

Posttest M

(SD)

(SD)

25.52

16.04

(15.57)

(15.41)

Note: low score indicates less decisional conflict
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t

df

p

4.49

14

.001

Research Question 4
Does the intervention increase patient’s anxiety?
To examine research question 4, a paired sample t-test was conducted to assess if there
were significant differences in patients’ anxiety over time (pretest vs. posttest). The results of the
paired-sample t - test were not significant, t (14) = 1.75, p = .102, suggesting that there was not a
significant difference in patients’ anxiety/stress scores over time. As can be seen from the means
reported in Table 6, moderate levels of anxiety were reported at both time points.

Table 6. Results of Paired Sample t Test for Anxiety/Stress Scores by Time (Pretest vs. Posttest)

Anxiety/stress

Pretest M

Posttest M

(SD)

(SD)

2.31

2.21

(0.33)

(0.33)

t

df

p

1.75

14

.102

Additional Analyses Assessing Intervention Fidelity and Timing
Intervention Fidelity
After the intervention, the Quality of Communication about EOL Form (Appendix I) was
used to ask participants to evaluate the interview and the interviewer and rate the overall quality
of the discussion. As depicted in Table 7, the intervention was delivered as intended. All
participants indicated they believed the patients’ treatment preferences would be honored
(congruence). All participants definitely felt the interviewer cared, listened, and gave
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participants enough attention (Interviewer fidelity). All participants were definitely satisfied with
the quality and effectiveness of communication (Interview fidelity).

Timing
All 10 patients and all seven surrogates who answered the question about timing
answered yes, it was a good time to have a discussion about ACP. However, one patient
specified that the best time would be one to two weeks after diagnosis because the discussion
would mean more when she “was still going through it.” However, three patients explicitly stated
that they liked the idea that the discussion occurred when they were not in crisis or heightened
distress. These patients made comments like “Good lapse between treatment and [Respecting
Choices] Interview,” “It is easier to let your feelings be known when you aren’t in a crisis”, and
“I have no active cancer to cause stress and affect my decision making process.” One surrogate
appreciated having the discussion before “it is too late” and two surrogates made comments like
“there is never a bad time” and that the discussion would be “appropriate at any time.”
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Table 7. Frequencies and Percentages for Analyses Assessing Intervention Fidelity and Timing
Patient

Surrogate

n

%

n

%

Probably yes

3

20.0

2

13.3

Definitely yes

12

80.0

13

86.7

Probably yes

-

-

1

6.7

Definitely yes

15

100.0

14

93.3

15

100.0

15

100.0

Probably yes

-

-

1

6.7

Definitely yes

15

100.0

14

93.3

Very good

4

26.7

4

26.7

Excellent

11

73.3

11

73.3

Question 1 – (Congruence)

Question 2 – (Interviewer fidelity)

Question 3 – (Interviewer fidelity)
Definitely yes
Question 4 – (Interviewer fidelity)

Question 5- (Interview fidelity)

Note : questions 1-4 ratings: 1= ‘no’ 2=probably yes 3= ‘definitely yes’. Question 5 ratings:
1=poor 2=fair 3=good 4= very good 5= excellent
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CHAPTER 5: DISCUSSION
Implications
This study investigated the impact of the Respecting Choices® DS ACP intervention on
patients with life-limiting cancer and their surrogates. Study findings were that participating in
the intervention significantly improved congruence between patients and surrogates regarding
EOL treatment preferences and reduced decisional conflict without causing anxiety. More
specifically, congruence between patients and matched surrogates for patient treatment
preferences significantly increased from pretest to posttest in all five situations. Feedback
obtained from the participants indicated that everyone who participated in this study found the
Respecting Choices® DS ACP intervention to be acceptable and beneficial.
Although it seems obvious that surrogates would have a greater understanding of
patients’ goals after an ACP discussion, most previous studies failed to show improved patientsurrogate dyadic congruence between patient and surrogate understanding after an ACP
intervention (Ditto et al., 2001; Hare et al., 1992; Layde et al., 1995; Matheis-Kraft &Roberto,
1997; Seckler et al., 1991; SUPPORT, 1995; Uhlmann et al., 1988; Wilkinson et al., 2007;
Zweibel & Cassel, 1989). The only studies that have found ACP to be effective in increasing
patient-surrogate dyadic congruence have included the elements that are incorporated into the
Respecting Choices DS ACP (Briggs, 2003; Briggs et al., 2005; Detering,et al.,2010; Kirchhoff,
et al.,2010; Lyon et al., 2009; Schwartz et al., 2002;Song et al., 2005). Thus, findings from this
study add to the body of literature that supports the essential elements of the Respecting Choices
intervention.
One of these Respecting Choices DS ACP elements places importance on surrogate
selection, specifically instructing patients to purposefully select a surrogate who is willing and
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capable of making decisions consistent with their values and goals (Briggs et al., 2004; Singer et
al. 1998, Schwartz et al., 2003). Consistent with this element, the researcher instructed patients
who expressed an interest in study participation to select a surrogate whom they believed could
best understand and support their wishes. Selected surrogates were required for study
participation, as the intervention was designed for surrogates to be included in the ACP
discussion. This requirement may have contributed to the success of the intervention because
chosen surrogates may have been more open to and interested in engaging in EOL discussions
than other people in the patients’ interpersonal networks.
Another Respecting Choices DS ACP element places importance on having a trained
facilitator guide the ACP discussion between the patient and surrogate. The requirement for
facilitator training acknowledges that discussing EOL is difficult for health professionals and lay
persons and additional communication skills are needed to help patients communicate their
wishes to surrogates. One of the reasons for this study’s success may be because the facilitator
successfully completed a certified training program and had the skills to help patients have more
effective EOL discussions with their surrogates.
The opportunity to discuss individual concerns is another key element in the Respecting
Choices ACP intervention. Discussing individual concerns includes helping patients reflect on
their goals and values and how these goals and values could direct treatment decisions. For
example, most patients in this study said initially that they were willing to accept a trial of
chemotherapy, regardless of their prognosis. With further discussion, the facilitator helped these
patients understand the possible outcomes of a chemotherapy trial and adjust their expectations
and clarify their wishes accordingly. In addition to reconsidering their general acceptance of
chemotherapy, these patients were able to articulate possible outcomes that would make
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acceptance of this treatment conditional. For example, patients identified loss of mental capacity
or the inability to take care of themselves as conditions for not trying another trial of
chemotherapy. Surrogates, by being present and engaged in the discussion, were better able to
understand what would be unacceptable outcomes for the patient. Skilled ACP facilitation that
included values clarification and included patient-surrogate communication about those values
were absent from interventions that were evaluated in studies that found the interventions
unsuccessful in improving patient-surrogate communication and congruence.
The perception that ACP discussions will raise anxiety and decrease hope in patients with
life limiting cancer was not supported in this study. Consistent with findings reported by
previous studies (see for example, Hancock et al., 2007; Lyon et al., 2009; Song et al., 2005;
Tang, Li, & Chen, 2008; Wright et al., 2008), this study found that talking about EOL is not
associated with greater distress or anxiety. More specifically, there were no significant
differences between the pre- and post-test measure of state anxiety. Nonetheless, it important to
note that anxiety was noted in patients when recruiting participants for this study. Not everyone
who was approached for possible study participation was willing to discuss EOL. In fact, most
participants reported that they were reluctant initially to discuss EOL issues. However, after
participating most of participants’ comments indicated that they were highly satisfied with the
intervention and relieved by discussing their EOL concerns. The number of participants who
actively recruited others to participate in the study is another testimony to participant satisfaction
and the relief they obtained by receiving the intervention.
Study findings also mostly support earlier research that indicates the ACP process should
occur early in the patient’s illness before crises occur (Briggs & Hammes, 2008/2010; Hiltunen
et al., 1999; Sulmasy et al., 1998). Patients participating in this study had either completed
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treatment or were receiving treatment because of recurrence. All participants who responded to
the question about Timing answered that after completing initial treatment was a good time
period to have a discussion about ACP. Only one participant commented that the best time would
be one to two weeks after diagnosis when she was still going through initial treatment.
The reasons for nonparticipation may also support the importance of having ACP
discussions early in the illness. Seven eligible participants who were referred from VIM and
initially expressed interest, were unable to participate because they were too ill from a recurrence
of cancer. For example, one patient was admitted to an intensive care unit shortly after being
referred to the study. Another reason for non-participation was that patients felt their loved ones
had already assumed too much burden as a result of their cancer recurrence and asking them to
participate in an EOL discussion would add to their burden. Perhaps these patients could have
benefited from having this ACP discussion at a less stressful time in their illness, before another
medical crisis occurred.

Limitations
There are a number of limitations that need to be considered when interpreting the study
findings. First, for ethical reasons to not withhold a highly promising intervention, the design
was not a randomized control trial (RCT). A RCT would provide the strongest evidence that it
was the intervention that increased patient-surrogate congruence. Without this design, it could be
argued that participants, by virtue of volunteering to take part in the intervention, were more
open to and perhaps more reflective about EOL issues. This possible explanation is particularly
applicable to one of the criteria for study participation, namely having a surrogate who was not
only willing to participate but also willing and capable of making decisions consistent with
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patient values and goals. However, it could also be argued that even people who are open and
reflective need a trained facilitator to fully understand treatment consequences and use this
understanding for clarifying and communicating EOL treatment preferences. These skills are
beyond most lay people, particularly when they are personally dealing with a life limiting illness.
As previously described, the facilitator in this study was a cancer expert with training in values
clarification and communication.
Second, the sample was homogenous with regard to racial background (i.e., all of the
participants were Caucasian). Racial and ethnic differences in ACP have been well documented
and particular ethnic groups may be resistant to different aspects of planning (Smith et al, 2007).
There is ample evidence that Caucasians are more likely to have ACP discussions than other
racial/ethnic groups (Carr et al., 2012; Rhoades & Teno, 2010). Therefore, caution needs to be
taken in generalizing results to racial or ethnic groups other than Caucasians.
Third, it is possible that reports of satisfaction with the intervention were biased by the
presence of the researcher when participants completed the Quality of Communication form. The
researcher delivered the intervention and, in part, was being evaluated by questions about the
quality of communication. Response burden also deserves consideration. Participants completed
the Quality of Communication form last, after an emotionally demanding discussion. They may
have been fatigued, which could have decreased the accuracy of their responses. However, it is
noteworthy that participants spontaneously offered positive comments about the intervention
before they were asked formally. For example, most patients and surrogates expressed feeling
relieved during the intervention when the facilitator assisted them to acknowledge and explore
emotionally distressing concerns about EOL.
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Fourth, the Respecting Choices DS ACP intervention was evaluated in its entirety rather
than evaluating each of the specific elements mentioned above. Thus, there is no way of
knowing if the success of the intervention can be attributed to any one element or a select
configuration of elements, such as delivery by a trained facilitator, surrogate selection, or the
focus on values and individual concerns. The strongest evidence for the conclusion that all of
the elements are essential comes from omission; that is that the literature contains evidence
interventions that were not successful in improving patient-surrogate congruence in EOL
decision making lacks one or more of these elements.
Finally, the Respecting Choices DS ACP intervention is adapted to be disease specific.
This adaptation requires that facilitators have some knowledge of the disease under
consideration. Previous studies have used nurses or allied health workers such as social workers
and chaplains (Briggs et al., 2004; Song et al., 2005) and (Detering et al., 2010: Kirchhoff et
al., 2010; Lyons et al., 2009). However these studies were of patients suffering from other
diseases, such as congestive heart, respiratory, or kidney failure. Life-limiting cancer may
require more mastery of the subject matter than these other diseases because numerous and
often controversial cancer treatment options are widely used. Allied health workers or nurses
without a specialization in cancer may not understand the numerous cancer treatment options.
Because the facilitator in this study was a nurse who has experience caring for patients
diagnosed with cancer and in EOL situations, it is not clear if study findings can be generalized
to facilitators who do not have this clinical training.
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Implication for Practice and Policy
The study findings provide information for a number of policy and practice changes for
ACP. First, participant reports of satisfaction with the intervention and the study finding that the
Respecting Choices® DS-ACP intervention did not increase anxiety can be used to persuade
oncologists and other health professionals that they need not be wary of referring patients for
EOL discussions with trained facilitators. As evidenced by the literature, oncologists and other
health professionals have often acted as gatekeepers who are reluctant to engage or refer patients
for ACP because of their wish to protect their patients from stressful discussions about EOL.
Their unsubstantiated concerns have limited referrals for ACP and are contributing to billions of
dollars in unwanted health care.
The success of the intervention demonstrated in this study for improving patientsurrogate communication about EOL decisions can also be used to influence health policy. Given
the relief and satisfaction expressed by participants, study findings support making the
intervention part of usual care at facilities and practices that provide care for patients with life
limiting cancer. Resources should be made available to train facilitators and make the
intervention accessible at these facilities and practices. If future research documents that
increased patient –surrogate congruence is indeed effective for respecting patient wishes at EOL,
then policies about training and access should be mandated.
Delivering this intervention during different stages in the progression of a patient's illness
or cancer progression was not compared in this study. This study did not make comparisons
about different times in the patient’s illness or cancer progression about when to deliver the
intervention. However, participant satisfaction with when the intervention was delivered in this
study supports delivering the intervention well before a medical crisis.
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Implications for Future Research
Future research is needed to determine if increased patient-surrogate congruence does
indeed lead to patients’ wishes being followed at EOL and reduces decisional conflict and stress
in surrogates. The recommended study design for this future research is a prospective one that
follows patients and surrogates post intervention through to patients’ EOL. As previously
discussed, a Phase I clinical trial was chosen for the present study for ethical reasons to not
withhold an intervention with promise. However, a comparative design that includes a naturally
occurring comparison group (i.e., those who receive the standard approach) could be used in a
future study to investigate the critical question of whether the intervention achieves these final
outcomes (patient wishes being followed and less surrogate decisional conflict and distress) at
EOL. For example, participants who receive the intervention could be followed prospectively to
compare EOL care with those who did not receive the intervention. Patients and surrogates who
did not receive the intervention could be recruited in the study at patients’ EOL for comparison,
thereby averting the ethical issue of withholding treatment.
Additional research is also needed with racial and ethnic groups whose reluctance to
engage in EOL discussion has been documented in the literature. This research is needed to
determine if the Respecting Choices DS ACP intervention is culturally appropriate or needs to
be modified when used with certain racial or ethnic groups. A recommended approach would
be to employ an exploratory qualitative design to understand group-specific values and
perspectives about ACP. For example, conducting focus groups with members of specific racial
or ethnic groups could generate informative discussions about within group similarities and
difference in preferred ACP approaches. Approaching racial or ethnic groups through
organizations that they trust, such as churches and matching the racial or ethnic background of
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the focus group facilitator might increase their willingness to participate in focus groups about
EOL values and perspectives.
Future research is also needed to determine which types of professionals are best suited
for the role of ACP facilitator for patients with life-limiting cancer. Since implementation of
the Respecting Choices DS ACP intervention is illness-specific and requires advanced
knowledge of specific illness and related treatment outcomes, it may be that facilitators need to
be health providers with a particular medical or nursing specialty. Since there are many types of
cancer and different cancer- and patient-specific treatments, specialization may be even more
important for intervening with patients with life limiting cancer. Thus future research is needed
to determine the knowledge base needed to effectively facilitate ACP with this population. A
comparative design is recommended to answer this research question. For example,
professionals with differing degrees of clinical specialty expertise could be compared for
participant satisfaction and patient-surrogate congruence as well as whether these intermediary
outcomes lead to the final outcomes respecting patients’ EOL wishes and decreasing surrogate
decisional conflict and distress at end of life. In addition, certified training programs for
preparing facilitators to deliver the Respecting Choices DS ACP intervention could contribute
to evaluating the question about the best educational preparation for becoming a certified
facilitator.
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APPENDIX A: STATEMENT FOR TREATMENT PREFERENCES FOR LIFELIMITING CANCER
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APPENDIX B: VERBAL ASSESSMENT QUESTIONS
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Do you understand that information in the advance directive contains choices that will be acted
upon in the future, not the present?
Do you understand that the preferences in the advance directive will be honored only when you
are no longer capable?
Do you understand the choice to select a surrogate decision maker and/or specify medical
preferences?
Do you understand that the choices made can be changed at any time?
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APPENDIX C: INTRODUCTORY LETTER
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My name is Lynn Waser. I am a Registered Nurse, and a doctoral candidate at the University of
Central Florida. I am also an Advanced Care Planning Facilitator. I am conducting a study on
assisting patients diagnosed with cancer to make plans for future medical treatments and
promoting respect for their choices.
The purpose of this study is to evaluate whether a specially designed advance care planning
interview concerning a patient’s medical care preferences and his/her chosen surrogate’s
preparation for future medical decision-making is beneficial. This study will address your wishes
and preferences for medical treatment if you became unable to make such decisions in the future.
You will need to select a surrogate, someone you might wish to make health care decisions for you,
should you become unable to make such decisions in the future. If your surrogate and you agree I
will interview you and your surrogate. The interview will provide an opportunity for you and your
surrogate to think about your future medical treatment choices in the context of your current
illness and promote your surrogate’s understanding of your preferences for medical treatment. For
this reason, your surrogate will be with you during the interview. The interview will be a 1 to 1½
hour discussion and will involve answering short questionnaires that should take no more than 30
minutes.
If you would be kind enough to write your name and phone number in the space below, I will
contact you to answer any questions you have regarding this study. You can also call me at: (Phone
Number)
Thank you
Lynn Waser MSN RN, Doctoral Candidate and Researcher
Your Name and Contact Phone Number or E-Mail: ___________________________________
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APPENDIX D: INFORMED CONSENT
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APPENDIX E: RESPECTING CHOICES ® DS-ACP INTERVIEW STAGES
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Respecting Choices Disease Specific Advance Care Planning Interview

Stage 1: Assess Illness Beliefs, Goals, and Values

The Respecting Choices ACP begins with the facilitator explaining the purpose of the
discussion as an opportunity for the patients and their surrogate to understand and think about the
life-sustaining treatment choices the patient would want if unable to make his or her own
decisions in the future. The ACP facilitator assesses patient and surrogate understandings of the
patient’s current medical condition, prognosis, and potential complications. The facilitator
explores how patients’ health conditions have affected their lives, what things are most
meaningful to them, and expectations for their current plan of care. As the interview progresses,
this information helps patients reflect on whether the burdens of particular life sustaining
treatment match their goals for living well (Briggs & Hammes, 2008/2010).

Stage 2: Exploring Experiences
The facilitator explores the patient’s experience with previous hospitalizations and with
family and friends who have been seriously ill or died. These conversations help the facilitator
assess what the patient learned and how those experiences may have helped or hindered the
patient’s ability to plan for the future. The facilitator also explores the quality of previous
advance care planning discussions with loved ones because while patients often feel they have
had enough discussion surrogates continue to lack understanding (Briggs & Hammes,
2008/2010).

Stage 3: Explaining the Purpose of Advance Care Planning
The facilitator weaves information gained from patients and surrogates during the first
two stages of the interview to help them understand the purpose of more specific advance care
planning. This discussion sets the stage for discussing specific medical decisions patients want
their chosen surrogates to understand and to act upon in the future. The goal is to prepare the
surrogates to be able to fully represent the patient’s wishes (Briggs & Hammes, 2008/2010).

Stage 4: Clarifying Goals for Life Sustaining Treatment Preferences
During the fourth element, the facilitator uses the statement of treatment preferences for
life-limiting cancer document to help patients express goals for life-sustaining treatment and
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prepare surrogates for the role for future substitute decision-maker. The scenarios describe real
situations, specific to life-limiting cancer that the patient may experience and types of treatment
decisions the surrogate might be asked to make. The ACP facilitator explains the benefits and
burdens of life-sustaining treatments and discusses the importance of choosing a healthcare
surrogate that can represent the patients’ decisions (Briggs & Hammes, 2008/2010).

Stage 5: Summary
During this element, the patient, surrogate, and ACP facilitator discuss the new
information and the value of the discussion for the patient and surrogate. Any outstanding issues
are raised. The need for future discussion as the situation and preferences change are reviewed
(Briggs & Hammes, 2008/2010).

Stage 6: Follow-up Plan
A plan about ways to communicate the written plan to health care providers and other
family members are developed. Referrals to appropriate resource, such as a social worker, will
be provided to address any issues that may have occurred during the interview (Briggs &
Hammes, 2008/2010).
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APPENDIX F: SOCIODEMOGRAPHIC INSTRUMENTS
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Socio Demographic Form for Respecting Choices DS-ACP Study (Patient
Version)

1) Age (please check one):
□
□
□
□
□
□
□
□
□
□

21-29
30-39
40-49
50-54
55-59
60-64
65-69
70-74
75-79
80 & up

2) Gender (please check one):
□ Male
□ Female

3) Marital Status (please check one):
□
□
□
□
□
□

Single
Married
Separated
Divorced
Widowed
Domestic Partnership

4) Religious Affiliation you were raised in (please check one):
□
□
□
□
□
□

Christian
Catholic
Jewish
Muslim
Hindu
Other
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5) Religious affiliation that you currently practice (please check one):
□
□
□
□
□
□

Christian
Catholic
Jewish
Muslim
Hindu
Other

6) How often do you attend religious services (please check one):
□
□
□
□
□

Once a week or more
About once a month
Holy Days and special occasions only
Never
Other (please specify):

7) Housing Status (please check one):
□ Home
□ Assisted Living Facility
□ Other (please specify): _________________________________________

8) Education Level (please check one):
□
□
□
□
□
□
□

Less than High School
High School Diploma/GED
Some College
Associates Degree
Bachelors Degree
Masters Degree
Doctorate

9) Occupation (please check one):
□
□
□
□
□
□

Administrative Support
Arts/Design/Entertainment
Business
Computer Technology
Construction
Education
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□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□

Engineers/Architects
Forestry - Agriculture
Food Service
Graphic Design
Healthcare
Homemaker or Parenting
Legal
Maintenance
Management
Military
Services
Repair/Installation
Sales
Science
Social Service
Transportation
Other (please specify)_______________________

10) Income Level (please check one):
□
□
□
□
□
□
□
□
□

$0-$9,999
$10,000-$19,999
$20,000-$34,999
$35,000-$44,999
$45,000-$54,999
$55,000-$64,999
$65,000-$74,999
$75,000-$99,999
$100,000 & up

11) Cancer Diagnosis (please check one):
□
□
□
□
□
□
□
□

Breast
Colon
Lung
Liver
Bone
Multiple Myeloma
Leukemia
Other (please specify): ___________________________________
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12) Relationship to Health Care Surrogate (please check one):
□
□
□
□
□
□
□

Spouse
Parent
Child
Sibling
Other Relative
Friend
Other (please specify): ___________________________________

13) Where and how did you hear about this study?

14) What is your understanding of your cancer diagnosis?
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Socio Demographic Form for Respecting Choices DS-ACP Study (Surrogate
Version)

1) Age (please check one):
□
□
□
□
□
□
□
□
□
□

21-29
30-39
40-49
50-54
55-59
60-64
65-69
70-74
75-79
80 & up

2) Gender (please check one):
□ Male
□ Female

3) Marital Status (please check one):
□
□
□
□
□
□

Single
Married
Separated
Divorced
Widowed
Domestic Partnership

4) Religious Affiliation that you were raised in (please check one):
□
□
□
□
□
□

Christian
Catholic
Jewish
Muslim
Hindu
Other
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5) Religious affiliation that you currently practice (please check one):
□
□
□
□
□
□

Christian
Catholic
Jewish
Muslim
Hindu
Other

6) How often do you attend religious services (please check one):
□
□
□
□
□

Once a week or more
About once a month
Holy Days and special occasions only
Never
Other (please specify):

7) Education Level (please check one):
□
□
□
□
□
□
□

Less than High School
High School Diploma/GED
Some College
Associates Degree
Bachelors Degree
Masters Degree
Doctorate

8) Occupation (please check one):
□
□
□
□
□
□
□
□
□
□
□
□
□

Administrative Support
Arts/Design/Entertainment
Business
Computer Technology
Construction
Education
Engineers/Architects
Forestry - Agriculture
Food Service
Graphic Design
Healthcare
Homemaker or Parenting
Legal
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□
□
□
□
□
□
□
□
□
□

Maintenance
Management
Military
Services
Repair/Installation
Sales
Science
Social Service
Transportation
other

9) Income Level (please check one):
□
□
□
□
□
□
□
□
□

$0-$9,999
$10,000-$19,999
$20,000-$34,999
$35,000-$44,999
$45,000-$54,999
$55,000-$64,999
$65,000-$74,999
$75,000-$99,999
$100,000 & up

10) Relationship to Patient (please check one):
□
□
□
□
□
□
□

Spouse
Child
Parent
Sibling
Other Relative
Friend
Other (please specify): ___________________________________

11) Where and how did you learn about this study?

12) What is your understanding of your loved ones cancer diagnosis?
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APPENDIX G: DECISIONAL CONFLICT SCALE
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APPENDIX H: SPIELBERGER STATE ANXIETY SCALES
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APPENDIX I: QUALITY OF COMMUNICATION ABOUT END-OF-LIFE CARE
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The quality of patient-interviewer communication about end-of-life care
(Completed by Patients)

ID# :
The following questions are to evaluate the discussion that you just had. Please show how you think
about the communication with these comments by circling the number from 1 (no) to 3 (definitely yes).
The last question is to rate overall quality of the discussion you had. Your answers are confidential.

No

Probably

Definitely yes

yes
Regarding the kinds of treatment you would want if you got too sick to speak for
yourself:
1. Do you think that your treatment
1
2
3
preferences are known?
When you talked about the kinds of treatment:
2. Did you feel that the interviewer cared

1

2

3

1

2

3

1

2

3

about you as a person?
3. Did you feel that the interviewer listened
to what you said?
4. Did you feel that the interviewer gave you
enough of her attention?
Ratings:

Poor

Fair

Good

Very

Excellent

good
How would you rate the overall quality of
the discussions you just had with the
interviewer about the kinds of treatment you
would want if you got too sick to speak for
your self?

1

2

3

4

5

Adapted from Schwartz, C. E., Merriman, M., Reed, G., & Hammes, B. J. (2004). Measuring patient treatment preferences in end-of-life
care research: Applications for advance care planning interventions and response shift research. Journal of Palliative Medicine, 7, 233245
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The quality of patient-interviewer communication about end-of-life care
(Completed by Surrogates)

ID# :
The following questions are to evaluate the discussion that you just had. Please show how you think
about the communication with these comments by circling the number from 1 (no) to 3 (definitely yes).
The last question is to rate overall quality of the discussion you just had. Your answers are confidential.

No

Probably

Definitely yes

yes
Regarding the kinds of treatment your loved one would want if he/she got too sick to
speak for him/herself:
1. Do you think that your loved one’s
1
2
3
treatment preferences are known?
When you talked about your loved one’s kinds of treatment:
2. Did you feel that the interviewer cared

1

2

3

1

2

3

1

2

3

about your loved one as a person?
3. Did you feel that the interviewer listened
to what you and your loved said?
4. Did you feel that the interviewer gave
enough of attention?
Poor

Fair

Good

Ratings:
How would you rate the overall quality of
the discussions you just had with the
interviewer about the kinds of treatment your
loved one would want if he/she got too sick
to speak for him/herself?

Very

Excellent

good

1

2

3

4

5

Adapted from Schwartz, C. E., Merriman, M., Reed, G., & Hammes, B. J. (2004). Measuring patient treatment preferences in end-of-life care
research: Applications for advance care planning interventions and response shift research. Journal of Palliative Medicine, 7, 233-245.
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